BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-156. [PMID: 11668491 DOI: 10.1002/ijc.1440] [Cited by in Crossref: 2531] [Cited by in F6Publishing: 2283] [Article Influence: 126.6] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Tang Z, Tian B, Ye S, Qin L, Xue Q, Sun R. Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients. J Cancer Res Clin Oncol 2006;132:515-20. [DOI: 10.1007/s00432-006-0098-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
2 Custodio Carretero AB, García Sáenz JA, González Larriba JL, Bobokova J, Calles Blanco A, Hernando Trancho F, García Paredes B, Rodríguez Lajusticia L, Díaz-Rubio García E. Adjuvant chemotherapy for early-stage non-small-cell lung cancer. Single-centre experience and literature review. Clin Transl Oncol 2008;10:560-71. [PMID: 18796373 DOI: 10.1007/s12094-008-0251-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Bupathi M, Kaseb A, Janku F. Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives. Onco Targets Ther 2014;7:1927-32. [PMID: 25364263 DOI: 10.2147/OTT.S46457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
4 Morris LE, Bloom GS, Frierson HF, Powell SM. Nucleotide variants within theIQGAP1 gene in diffuse-type gastric cancers. Genes Chromosom Cancer 2005;42:280-6. [DOI: 10.1002/gcc.20150] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
5 Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, Lesaffre E, Libbrecht L, Desmet V, Roskams T. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology. 2006;49:138-151. [PMID: 16879391 DOI: 10.1111/j.1365-2559.2006.02468.x] [Cited by in Crossref: 268] [Cited by in F6Publishing: 245] [Article Influence: 17.9] [Reference Citation Analysis]
6 Hemminki K, Sundquist J, Ji J. Familial risk for gastric carcinoma: an updated study from Sweden. Br J Cancer. 2007;96:1272-1277. [PMID: 17406355 DOI: 10.1038/sj.bjc.6603722] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
7 Kim HK, Park WS, Kang SH, Warda M, Kim N, Ko JH, Prince Ael-B, Han J. Mitochondrial alterations in human gastric carcinoma cell line. Am J Physiol Cell Physiol. 2007;293:C761-C771. [PMID: 17537807 DOI: 10.1152/ajpcell.00043.2007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
8 Altomonte J, Braren R, Schulz S, Marozin S, Rummeny EJ, Schmid RM, Ebert O. Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats. Hepatology 2008;48:1864-73. [PMID: 19003878 DOI: 10.1002/hep.22546] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
9 Zhang X, Gee H, Rose B, Lee CS, Clark J, Elliott M, Gamble JR, Cairns MJ, Harris A, Khoury S, Tran N. Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers. BMC Cancer 2016;16:86. [PMID: 26867589 DOI: 10.1186/s12885-016-2109-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
10 Moore RS. Impact of Culture, Education and Socio-Economic Status. In: Williams CKO, Olopade OI, Falkson CI, editors. Breast Cancer in Women of African Descent. Dordrecht: Springer Netherlands; 2006. pp. 313-32. [DOI: 10.1007/978-1-4020-3664-4_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Gulmez A. Breast cancer after multiple myeloma treatment. Curr Probl Cancer 2019;43:100463. [PMID: 30738577 DOI: 10.1016/j.currproblcancer.2019.01.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Sharma A, Matharu Z, Sumana G, Solanki PR, Kim C, Malhotra B. Antibody immobilized cysteamine functionalized-gold nanoparticles for aflatoxin detection. Thin Solid Films 2010;519:1213-8. [DOI: 10.1016/j.tsf.2010.08.071] [Cited by in Crossref: 101] [Cited by in F6Publishing: 66] [Article Influence: 9.2] [Reference Citation Analysis]
13 Roscio F, Bertoglio C, De Luca A, Frattini P, Scandroglio I. Totally laparoscopic versus laparoscopic assisted right colectomy for cancer. Int J Surg. 2012;10:290-295. [PMID: 22564829 DOI: 10.1016/j.ijsu.2012.04.020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
14 You K, Liang X, Qin F, Guo Y, Geng L. High-risk human papillomavirus DNA testing and high-grade cervical intraepithelial lesions. Aust N Z J Obstet Gynaecol 2007;47:141-4. [PMID: 17355305 DOI: 10.1111/j.1479-828X.2007.00701.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
15 Cotrim HP, Oliveira CP, Coelho HS, Alvares-da-Silva MR, Nabuco L, Parise ER, Ivantes C, Martinelli AL, Galizzi-Filho J, Carrilho FJ. Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey. Clinics (Sao Paulo). 2016;71:281-284. [PMID: 27276398 DOI: 10.6061/clinics/2016(05)07] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
16 Harford JB, Edwards BK, Nandakumar A, Ndom P, Capocaccia R, Coleman MP; ICCC-3 Session A Group. Cancer control-planning and monitoring population-based systems. Tumori 2009;95:568-78. [DOI: 10.1177/030089160909500501] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
17 Andriani F, Conte D, Mastrangelo T, Leon M, Ratcliffe C, Roz L, Pelosi G, Goldstraw P, Sozzi G, Pastorino U. Detecting lung cancer in plasma with the use of multiple genetic markers. Int J Cancer 2004;108:91-6. [DOI: 10.1002/ijc.11510] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
18 Llovet JM. Evidence-based medicine in the treatment of hepatocellular carcinoma: Evidence-based treatment of HCC. Journal of Gastroenterology and Hepatology 2002;17:S428-33. [DOI: 10.1046/j.1440-1746.17.s3.40.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
19 Phillips RJ, Helbig KJ, Hoek KHVD, Seth D, Beard MR. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 2012; 18(26): 3389-3399 [PMID: 22807608 DOI: 10.3748/wjg.v18.i26.3389] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
20 Martins SF, Mariano V, Rodrigues M, Longatto-Filho A. Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma. Infect Agent Cancer 2020;15:17. [PMID: 32165915 DOI: 10.1186/s13027-020-00281-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Giri TK, Mukherjee P, Barman TK, Maity S. Nano-encapsulation of capsaicin on lipid vesicle and evaluation of their hepatocellular protective effect. International Journal of Biological Macromolecules 2016;88:236-43. [DOI: 10.1016/j.ijbiomac.2016.03.056] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
22 Yao Y, Tao H, Kim JJ, Burkhead B, Carloni E, Gasbarrini A, Sepulveda AR. Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines. Lab Invest. 2004;84:915-922. [PMID: 15133479 DOI: 10.1038/labinvest.3700117] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
23 Langer CJ, Natale RB. The Emerging Role of Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors. Seminars in Oncology 2005;32:23-9. [DOI: 10.1053/j.seminoncol.2005.10.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
24 Lowe KA, Chia VM, Taylor A, O'Malley C, Kelsh M, Mohamed M, Mowat FS, Goff B. An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol 2013;130:107-14. [PMID: 23558050 DOI: 10.1016/j.ygyno.2013.03.026] [Cited by in Crossref: 126] [Cited by in F6Publishing: 117] [Article Influence: 15.8] [Reference Citation Analysis]
25 Zheng R, Zeng H, Zhang S, Chen T, Chen W. National estimates of cancer prevalence in China, 2011. Cancer Lett. 2016;370:33-38. [PMID: 26458996 DOI: 10.1016/j.canlet.2015.10.003] [Cited by in Crossref: 107] [Cited by in F6Publishing: 119] [Article Influence: 17.8] [Reference Citation Analysis]
26 Brookman-Amissah S, May M, Albrecht K, Herrmann T, Roigas J, Gilfrich CP, Pflanz S, Gunia S. Urinary collecting system invasion reflects adverse long-term outcome and is associated with simultaneous metastatic spread at the time of surgery and with multilocular dissemination during postsurgical follow-up in renal cell cancer. World J Urol 2010;28:103-9. [PMID: 19479264 DOI: 10.1007/s00345-009-0426-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
27 Leung WK, To KF, Man EP, Chan MW, Bai AH, Hui AJ, Chan FK, Lee JF, Sung JJ. Detection of epigenetic changes in fecal DNA as a molecular screening test for colorectal cancer: a feasibility study. Clin Chem. 2004;50:2179-2182. [PMID: 15502094 DOI: 10.1373/clinchem.2004.039305] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
28 Boyle P, Leon M, Maisonneuve P, Autier P. Cancer control in women. Update 2003. International Journal of Gynecology & Obstetrics 2003;83:179-202. [DOI: 10.1016/s0020-7292(03)90121-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
29 Poma P, Labbozzetta M, Vivona N, Porcasi R, D'alessandro N, Notarbartolo M. Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma. OMICS: A Journal of Integrative Biology 2012;16:579-88. [DOI: 10.1089/omi.2012.0048] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
30 Saxton JM. Diet, physical activity and energy balance and their impact on breast and prostate cancers. Nutr Res Rev 2006;19:197-215. [PMID: 19079886 DOI: 10.1017/S095442240720294X] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Maione P, Rossi A, Airoma G, Ferrara C, Castaldo V, Gridelli C. The role of targeted therapy in non-small cell lung cancer. Critical Reviews in Oncology/Hematology 2004;51:29-44. [DOI: 10.1016/j.critrevonc.2004.02.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
32 Norum J. Cetuximab in the treatment of metastatic colorectal cancer: a model-based cost-effectiveness analysis. J Chemother 2006;18:532-7. [PMID: 17127231 DOI: 10.1179/joc.2006.18.5.532] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
33 Su C, Huang LL, Huang L, Lee J, Lin C, Won S. Caspase-8 acts as a key upstream executor of mitochondria during justicidin A-induced apoptosis in human hepatoma cells. FEBS Letters 2006;580:3185-91. [DOI: 10.1016/j.febslet.2006.04.085] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
34 Dai X, Ding J, Zhang R, Ren J, Ma CC, Wu G. Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway. International Journal of Radiation Biology 2013;89:724-31. [DOI: 10.3109/09553002.2013.791405] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
35 Díaz-Sánchez A, Matilla A, Núñez O, Merino B, Peligros I, Rincón D, Salcedo M, Lo Iacono O, Vega Catalina M, Clemente G, Bañares R. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival]. Gastroenterol Hepatol 2010;33:155-64. [PMID: 19945770 DOI: 10.1016/j.gastrohep.2009.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
36 Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H. An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics 2014;96:253-62. [PMID: 24275569 DOI: 10.1016/j.jprot.2013.11.014] [Cited by in Crossref: 154] [Cited by in F6Publishing: 143] [Article Influence: 19.3] [Reference Citation Analysis]
37 Passardi A, Cecconetto L, Dall'agata M, Dazzi C, Pasquini E, Oliverio G, Zumaglini F, Zoli W, Nanni O, Milandri C, Frassineti GL, Amadori D. Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer. J Transl Med 2008;6:65. [PMID: 18976450 DOI: 10.1186/1479-5876-6-65] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
38 Kanamori T, Shimizu M, Okuno M, Matsushima-nishiwaki R, Tsurumi H, Kojima S, Moriwaki H. Synergistic growth inhibition by acyclic retinoid and vitamin K 2 in human hepatocellular carcinoma cells. Cancer Science 2007;98:431-7. [DOI: 10.1111/j.1349-7006.2006.00384.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
39 Fatourou EM, Koskinas JS. Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications. Expert Review of Anticancer Therapy 2014;9:1499-510. [DOI: 10.1586/era.09.103] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
40 Giannelli G, Antonaci S. New frontiers in biomarkers for hepatocellular carcinoma. Dig Liver Dis 2006;38:854-9. [PMID: 16782417 DOI: 10.1016/j.dld.2006.05.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
41 Hui D, Qiang L, Jian W, Ti Z, Da-Lu K. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma. Dig Liver Dis. 2009;41:36-41. [PMID: 18818130 DOI: 10.1016/j.dld.2008.04.007] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 7.5] [Reference Citation Analysis]
42 Katz AW, Chawla S, Qu Z, Kashyap R, Milano MT, Hezel AF. Stereotactic Hypofractionated Radiation Therapy as a Bridge to Transplantation for Hepatocellular Carcinoma: Clinical Outcome and Pathologic Correlation. International Journal of Radiation Oncology*Biology*Physics 2012;83:895-900. [DOI: 10.1016/j.ijrobp.2011.08.032] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 7.2] [Reference Citation Analysis]
43 Luo W, Numata K, Morimoto M, Oshima T, Ueda M, Okada M, Takebayashi S, Zhou X, Tanaka K. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma. Eur J Radiol. 2010;75:91-97. [PMID: 19361941 DOI: 10.1016/j.ejrad.2009.03.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
44 Chen L, Wu JB, Lei F, Qian S, Hai L, Wu Y. Synthesis and biological evaluation of oleanolic acid derivatives as antitumor agents. J Asian Nat Prod Res 2012;14:355-63. [PMID: 22375874 DOI: 10.1080/10286020.2011.654110] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
45 Madhusudhan C, Saluja SS, Pal S, Ahuja V, Saran P, Dash NR, Sahni P, Chattopadhyay TK. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus. 2009;22:331-336. [PMID: 19473211 DOI: 10.1111/j.1442-2050.2008.00906.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
46 Siegel AB, Lim EA, Wang S, Brubaker W, Rodriguez RD, Goyal A, Jacobson JS, Hershman DL, Verna EC, Zaretsky J, Halazun K, Dove L, Brown RS, Neugut AI, Kato T, Remotti H, Coppleson YJ, Emond JC. Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation. 2012;94:539-543. [PMID: 22864187 DOI: 10.1097/tp.0b013e31825c58ea] [Cited by in Crossref: 50] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
47 Siegel AB, Mcbride RB, El-serag HB, Hershman DL, Brown RS, Renz JF, Emond J, Neugut AI. Racial Disparities in Utilization of Liver Transplantation for Hepatocellular Carcinoma in the United States, 1998–2002. Am J Gastroenterol 2008;103:120-7. [DOI: 10.1111/j.1572-0241.2007.01634.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
48 Chen JM, Chen PY, Lin CC, Hsieh MC, Lin JT. Antimetastatic Effects of Sesamin on Human Head and Neck Squamous Cell Carcinoma through Regulation of Matrix Metalloproteinase-2. Molecules 2020;25:E2248. [PMID: 32397656 DOI: 10.3390/molecules25092248] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
49 Patel BP, Rawal UM, Shah PM, Prajapati JA, Rawal RM, Dave TK, Patel PS. Study of tobacco habits and alterations in enzymatic antioxidant system in oral cancer. Oncology 2005;68:511-9. [PMID: 16037684 DOI: 10.1159/000086995] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
50 Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology. 2010;52:60-70. [PMID: 20578129 DOI: 10.1002/hep.23660] [Cited by in Crossref: 250] [Cited by in F6Publishing: 244] [Article Influence: 22.7] [Reference Citation Analysis]
51 Farnam JL, Smith BC, Johnson BR, Estrada R, Edelman TL, Farah R, Cressman EN. Thermochemical ablation in an ex-vivo porcine liver model using acetic acid and sodium hydroxide: proof of concept. J Vasc Interv Radiol 2010;21:1573-8. [PMID: 20801679 DOI: 10.1016/j.jvir.2010.06.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
52 Adeloye D, Harhay MO, Ayepola OO, Dos Santos JP, David RA, Ogunlana OO, Gadanya M, Osamor VC, Amuta AO, Iweala EE, Auta A, Rebbeck TR. Estimate of the incidence of bladder cancer in Africa: A systematic review and Bayesian meta-analysis. Int J Urol 2019;26:102-12. [PMID: 30345565 DOI: 10.1111/iju.13824] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
53 Le Roux E, Gormally E, Hainaut P. Somatic mutations in human cancer: applications in molecular epidemiology. Revue d'Épidémiologie et de Santé Publique 2005;53:257-66. [DOI: 10.1016/s0398-7620(05)84603-6] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
54 Planchard D, Bourgeois H, Adoun M, Paitel JF, Blanc P, Genet D, Ferru A, Meurice JC, Deletage C, Tourani JM. Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer: results of a phase II study. Am J Clin Oncol 2006;29:345-51. [PMID: 16891860 DOI: 10.1097/01.coc.0000221320.81753.a9] [Reference Citation Analysis]
55 Shi JH, Line PD. Effect of liver regeneration on malignant hepatic tumors. World J Gastroenterol 2014; 20(43): 16167-16177 [PMID: 25473170 DOI: 10.3748/wjg.v20.i43.16167] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.9] [Reference Citation Analysis]
56 Mohamed EA, Giama NH, Shaleh HM, Kerandi L, Oseini AM, Ahmed Mohammed H, Kerandi H, Allotey LK, Waaeys IA, Ali HA, Ali HM, Mohamed SA, Yang JD, Gaga WO, Tamire LL, Windissa A, Patten CA, Balls-Berry JE, Roberts LR. Knowledge, Attitudes, and Behaviors of Viral Hepatitis Among Recent African Immigrants in the United States: A Community Based Participatory Research Qualitative Study. Front Public Health 2020;8:25. [PMID: 32211358 DOI: 10.3389/fpubh.2020.00025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
57 Mohammed ZM, Going JJ, Edwards J, Elsberger B, Doughty JC, McMillan DC. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer 2012;107:864-73. [PMID: 22878371 DOI: 10.1038/bjc.2012.347] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 9.1] [Reference Citation Analysis]
58 Bhattacharya N, Sabbir MG, Roy A, Dam A, Roychoudhury S, Panda CK. Approximately 580 Kb surrounding the MYC gene is amplified in head and neck squamous cell carcinoma of Indian patients. Pathol Res Pract 2005;201:691-7. [PMID: 16325511 DOI: 10.1016/j.prp.2005.08.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
59 Kang S, Kim YS, Choi HJ, Kim M, Cho K. Additional Value of Combined Evaluation of Tumor Size With Lymph Node Size in the Detection of Lymph Node Metastases in Early-Stage Cervical Cancer Patients: . Journal of Computer Assisted Tomography 2013;37:572-6. [DOI: 10.1097/rct.0b013e31828ba718] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
60 Lu J, Hsia Y, Tu H, Hsiao Y, Yang W, Wang H, Yuh C. Liver development and cancer formation in zebrafish. Birth Defects Research Part C: Embryo Today: Reviews 2011;93:157-72. [DOI: 10.1002/bdrc.20205] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
61 Grunewald TG, Kammerer U, Winkler C, Schindler D, Sickmann A, Honig A, Butt E. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br J Cancer 2007;96:296-305. [PMID: 17211471 DOI: 10.1038/sj.bjc.6603545] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 6.6] [Reference Citation Analysis]
62 Clarke SJ, Boyer MJ, Millward M, Underhill C, Moylan E, Yip D, White S, Childs A, Beale P, Latz J, Suri A, Iglesias JL. A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer. Lung Cancer 2005;49:401-12. [DOI: 10.1016/j.lungcan.2005.04.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
63 Beglin M, Melar-New M, Laimins L. Human papillomaviruses and the interferon response. J Interferon Cytokine Res 2009;29:629-35. [PMID: 19715460 DOI: 10.1089/jir.2009.0075] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
64 Tanaka Y, Murata M, Shen CH, Furue M, Ito T. NECTIN4: A Novel Therapeutic Target for Melanoma. Int J Mol Sci 2021;22:976. [PMID: 33478111 DOI: 10.3390/ijms22020976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
65 Escarda A, Vaquer P, Bonet L, Miralbés S, Gómez C, Obrador A. [Clivus metastasis from hepatocarcinoma associated with transarterial hepatic chemoembolization]. Gastroenterol Hepatol 2006;29:401-4. [PMID: 16938255 DOI: 10.1157/13091453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
66 Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML, Wu XT. Interleukin-10 -1082 promoter polymorphism associated with gastric cancer among Asians. Eur J Cancer. 2008;44:2648-2654. [PMID: 18707865 DOI: 10.1016/j.ejca.2008.07.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
67 Alraiyes AH, Altahawi F, Shaheen K, Alraies MC. Abdominal pain and heart failure: a grim diagnosis. Am J Med 2012;125:34-6. [PMID: 22055250 DOI: 10.1016/j.amjmed.2011.07.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Ueda J, Yoshida H, Mamada Y, Taniai N, Mineta S, Yoshioka M, Kawano Y, Shimizu T, Hara E, Kawamoto C, Kaneko K, Uchida E. Surgical resection of a solitary para-aortic lymph node metastasis from hepatocellular carcinoma. World J Gastroenterol 2012; 18(23): 3027-3031 [PMID: 22736929 DOI: 10.3748/wjg.v18.i23.3027] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
69 Jiang Y, Shu Y, Shi Y, Li LP, Yuan F, Ren H. Identifying gastric cancer related genes using the shortest path algorithm and protein-protein interaction network. Biomed Res Int 2014;2014:371397. [PMID: 24729971 DOI: 10.1155/2014/371397] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
70 Sanchez-Cespedes M. The role of LKB1 in lung cancer. Fam Cancer. 2011;10:447-453. [PMID: 21516316 DOI: 10.1007/s10689-011-9443-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
71 Roy L, Laboissière S, Abdou E, Thibault G, Hamel N, Taheri M, Boismenu D, Lanoix J, Kearney RE, Paiement J. Proteomic analysis of the transitional endoplasmic reticulum in hepatocellular carcinoma: an organelle perspective on cancer. Biochim Biophys Acta. 2010;1804:1869-1881. [PMID: 20576523 DOI: 10.1016/j.bbapap.2010.05.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
72 Hijona E, Banales JM, Hijona L, Medina JF, Arenas J, Herreros-Villanueva M, Aldazabal P, Bujanda L. Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models. Cancer Cell Int 2012;12:5. [PMID: 22353776 DOI: 10.1186/1475-2867-12-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
73 Bano N, Yadav M, Das BC. Differential Inhibitory Effects of Curcumin Between HPV+ve and HPV-ve Oral Cancer Stem Cells. Front Oncol 2018;8:412. [PMID: 30319975 DOI: 10.3389/fonc.2018.00412] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
74 Wu WY, Yang XB, Deng H, Long SQ, Sun LS, He WF, Zhou YS, Liao GY, Chan SM, Shan SP. Treatment of advanced non-small cell lung cancer with extracorporeal high frequency thermotherapy combined with Chinese medicine. Chin J Integr Med 2010;16:406-10. [PMID: 20872115 DOI: 10.1007/s11655-010-0535-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
75 Rajyaguru DJ, Borgert AJ, Smith AL, Thomes RM, Conway PD, Halfdanarson TR, Truty MJ, Kurup AN, Go RS. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database. J Clin Oncol. 2018;36:600-608. [PMID: 29328861 DOI: 10.1200/jco.2017.75.3228] [Cited by in Crossref: 88] [Cited by in F6Publishing: 39] [Article Influence: 29.3] [Reference Citation Analysis]
76 Rehman S, Husnain SM. A probable risk factor of female breast cancer: study on benign and malignant breast tissue samples. Biol Trace Elem Res 2014;157:24-9. [PMID: 24254879 DOI: 10.1007/s12011-013-9865-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
77 Rybnikova NA, Haim A, Portnov BA. Is prostate cancer incidence worldwide linked to artificial light at night exposures? Review of earlier findings and analysis of current trends. Arch Environ Occup Health 2017;72:111-22. [PMID: 27029744 DOI: 10.1080/19338244.2016.1169980] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
78 Bonnetain F, Paoletti X, Collette S, Doffoel M, Bouché O, Raoul JL, Rougier P, Masskouri F, Barbare JC, Bedenne L. Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials. Qual Life Res 2008;17:831-43. [PMID: 18618292 DOI: 10.1007/s11136-008-9365-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
79 Bau D, Tsai C, Wu C. Role of the XRCC5/XRCC6 dimer in carcinogenesis and pharmacogenomics. Pharmacogenomics 2011;12:515-34. [DOI: 10.2217/pgs.10.209] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
80 Lee JM, Choi BI. Hepatocellular nodules in liver cirrhosis: MR evaluation. Abdom Imaging 2011;36:282-9. [DOI: 10.1007/s00261-011-9692-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
81 Zheng B, Zhu YJ, Wang HY, Chen L. Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms. Sci China Life Sci. 2017;60:575-584. [PMID: 28547581 DOI: 10.1007/s11427-016-9043-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
82 Mehta S, Rajaram S, Goel G, Goel N. Awareness about Human Papilloma Virus and its Vaccine Among Medical Students. Indian J Community Med 2013;38:92-4. [PMID: 23878421 DOI: 10.4103/0970-0218.112438] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
83 Zhao Y, Qi X, Chen J, Wei W, Yu C, Yan H, Pu M, Li Y, Miao L, Li C, Ren J. The miR-491-3p/Sp3/ABCB1 axis attenuates multidrug resistance of hepatocellular carcinoma. Cancer Lett. 2017;408:102-111. [PMID: 28844709 DOI: 10.1016/j.canlet.2017.08.027] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
84 Rossi A, Maione P, Colantuoni G, Gaizo FD, Guerriero C, Nicolella D, Ferrara C, Gridelli C. Screening for lung cancer: New horizons? Critical Reviews in Oncology/Hematology 2005;56:311-20. [DOI: 10.1016/j.critrevonc.2005.04.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
85 Chen J, Li T, Wu Y, He L, Zhang L, Shi T, Yi Z, Liu M, Pang X. Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis. J Cancer Res Clin Oncol. 2011;137:1799-1812. [PMID: 21918901 DOI: 10.1007/s00432-011-1057-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
86 Gerestein C, Eijkemans M, de Jong D, van der Burg M, Dykgraaf R, Kooi G, Baalbergen A, Burger C, Ansink A. The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma. BJOG: An International Journal of Obstetrics & Gynaecology 2009;116:372-80. [DOI: 10.1111/j.1471-0528.2008.02033.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
87 Zhu C, Wang J, Liu W, Chen L, Abdelrahim ME, Ren L. Ginseng Consumption Possible Effect on Liver Cancer: A Meta-Analysis. Nutr Cancer 2021;73:1581-9. [PMID: 32757804 DOI: 10.1080/01635581.2020.1803929] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Wang C, Li W, Hu B. The anti-tumor effect of folate-targeted liposome microbubbles loaded with oridonin as ultrasound-triggered tumor-targeted therapeutic carrier system. Journal of Drug Targeting 2016;25:83-91. [DOI: 10.1080/1061186x.2016.1200588] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.6] [Reference Citation Analysis]
89 Kai AK, Chan LK, Lo RC, Lee JM, Wong CC, Wong JC, Ng IO. Down-regulation of TIMP2 by HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma. Hepatology 2016;64:473-87. [PMID: 27018975 DOI: 10.1002/hep.28577] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 10.8] [Reference Citation Analysis]
90 Nakanishi Y, Shiraha H, Nishina S, Tanaka S, Matsubara M, Horiguchi S, Iwamuro M, Takaoka N, Uemura M, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yagi T, Yamamoto K. Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis. BMC Cancer 2011;11:3. [PMID: 21205319 DOI: 10.1186/1471-2407-11-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
91 Wang T, Chuan Pan C, Rui Yu J, Long Y, Hong Cai X, De Yin X, Qiong Hao L, Li Luo L. Association between TYMS expression and efficacy of pemetrexed-based chemotherapy in advanced non-small cell lung cancer: a meta-analysis. PLoS One 2013;8:e74284. [PMID: 24040222 DOI: 10.1371/journal.pone.0074284] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
92 Ping Z, Xu H, Liu T, Huang J, Meng Y, Xu X, Li W, Zhang L. Anti-hepatoma activity of the stiff branched β- d -glucan and effects of molecular weight. J Mater Chem B 2016;4:4565-73. [DOI: 10.1039/c6tb01299j] [Cited by in Crossref: 26] [Article Influence: 5.2] [Reference Citation Analysis]
93 Jang KS, Paik SS, Chung H, Oh YH, Kong G. MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. Cancer Sci 2006;97:374-9. [PMID: 16630134 DOI: 10.1111/j.1349-7006.2006.00186.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 4.9] [Reference Citation Analysis]
94 Tse L, Yu IT, Mang OW. Time trends of esophageal cancer in Hong Kong: Age, period and birth cohort analyses: Trends of Esophageal Cancer Incidence in Hong Kong. Int J Cancer 2007;120:853-8. [DOI: 10.1002/ijc.22382] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
95 Maddams J, Utley M, Møller H. Levels of acute health service use among cancer survivors in the United Kingdom. European Journal of Cancer 2011;47:2211-20. [DOI: 10.1016/j.ejca.2011.04.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
96 Araya Mezgebo T, Niguse S, Gebrekidan Kahsay A, Hailekiros H, Berhe N, Asmelash Dejene T. Hepatitis B virus infection and associated risk factors among pregnant women attending antenatal care in health facilities of Tigray, Northern Ethiopia. J Med Virol 2018;90:503-9. [PMID: 29077204 DOI: 10.1002/jmv.24987] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
97 Fenoglio L, Serraino C, Castagna E, Cardellicchio A, Pomero F, Grosso M, Senore C. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases. World J Gastroenterol 2013; 19(21): 3207-3216 [PMID: 23745022 DOI: 10.3748/wjg.v19.i21.3207] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
98 Marchetti I, Zavaglia K, Bertacca G, Aretini P, Matteoli B, Viacava P, Prato B, De Punzio C, Genazzani A, Bevilacqua G, Di Coscio G. HPV Testing and Pap Test: Role for a Combined Approach in a Non-Screened Population. Int J Biol Markers 2006;21:149-56. [DOI: 10.1177/172460080602100303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
99 Wiedmann M, Zeh J, Schoppmeyer K, Moebius C, Niederhagen M, Wittekind C, Mossner J, Caca K. Bendamustine--a new approach to the treatment of advanced hepatocellular carcinoma? J Chemother 2008;20:112-8. [PMID: 18343753 DOI: 10.1179/joc.2008.20.1.112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Maitra A, Kern SE, Hruban RH. Molecular pathogenesis of pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:211-26. [PMID: 16549325 DOI: 10.1016/j.bpg.2005.10.002] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 7.5] [Reference Citation Analysis]
101 Ohnishi H, Sakaguchi K, Nouso K, Kobayashi Y, Nakamura S, Tanaka H, Miyake Y, Shoji B, Iwadou S, Shiratori Y. Outcome of small liver nodules detected by computed tomographic angiography in patients with hepatocellular carcinoma. Hepatol Int 2010;4:562-8. [PMID: 21063478 DOI: 10.1007/s12072-010-9190-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
102 Jia Z, Tian F, Jiang G. Ruptured hepatic carcinoma after transcatheter arterial chemoembolization. Curr Ther Res Clin Exp. 2013;74:41-43. [PMID: 24384870 DOI: 10.1016/j.curtheres.2012.12.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
103 Zavalishina LÉ, Andreeva II, Vinogradov II, Danilova NV, Kuznetsova OA, Frank GA. [Comparative study of the determination of the HER2 status in gastric cancer in the biopsy and intraoperative specimens]. Arkh Patol 2014;76:22-7. [PMID: 25842922 DOI: 10.17116/patol201476622-27] [Reference Citation Analysis]
104 Hu X, Su J, Zhou Y, Xie X, Peng C, Yuan Z, Chen X. Repressing CD147 is a novel therapeutic strategy for malignant melanoma. Oncotarget 2017;8:25806-13. [PMID: 28445958 DOI: 10.18632/oncotarget.15709] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
105 Ling ZQ, Qi CJ, Lu XX, Qian LJ, Gu LH, Zheng ZG, Zhao Q, Wang S, Fang XH, Yang ZX, Yin J, Mao WM. Heterogeneity of chemosensitivity in esophageal cancer using ATP-tumor chemosensitivity assay. Acta Pharmacol Sin. 2012;33:401-406. [PMID: 22286916 DOI: 10.1038/aps.2011.195] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
106 Kim DH, Cho E, Cho SB, Choi SK, Kim S, Yu J, Koh YI, Sim DW, Jun CH. Complete response of hepatocellular carcinoma with right atrium and pulmonary metastases treated by combined treatments (a possible treatment effect of natural killer cell): A case report and literature review. Medicine (Baltimore) 2018;97:e12866. [PMID: 30334999 DOI: 10.1097/MD.0000000000012866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
107 Tanaka Y, Kato K, Mibu R, Uchida S, Asanoma K, Hashimoto K, Nozaki M, Wake N. Medroxyprogesterone acetate inhibits proliferation of colon cancer cell lines by modulating cell cycle-related protein expression. Menopause 2008;15:442-53. [DOI: 10.1097/gme.0b013e318156fb77] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
108 Perez-Plasencia C, Duenas-Gonzalez A, Alatorre-Tavera B. Second hit in cervical carcinogenesis process: involvement of wnt/beta catenin pathway. Int Arch Med 2008;1:10. [PMID: 18606007 DOI: 10.1186/1755-7682-1-10] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
109 Wang J, Qin Y, Li B, Sun Z, Yang B. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients. Clin Biochem. 2006;39:344-348. [PMID: 16527261 DOI: 10.1016/j.clinbiochem.2006.01.008] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
110 Kamaraj S, Anandakumar P, Jagan S, Ramakrishnan G, Devaki T. Hesperidin attenuates mitochondrial dysfunction during benzo(a)pyrene-induced lung carcinogenesis in mice. Fundam Clin Pharmacol 2011;25:91-8. [PMID: 20199583 DOI: 10.1111/j.1472-8206.2010.00812.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
111 Yuh D, Chang T, Huang R, Chien W, Lin F, Fu E. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan. Journal of Dentistry 2014;42:1343-52. [DOI: 10.1016/j.jdent.2014.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
112 Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene 2010;29:2309-24. [PMID: 20228847 DOI: 10.1038/onc.2010.36] [Cited by in Crossref: 184] [Cited by in F6Publishing: 173] [Article Influence: 16.7] [Reference Citation Analysis]
113 Wang X, Wang J, Ma H, Zhang J, Zhou X. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol. 2012;29:919-927. [PMID: 21390519 DOI: 10.1007/s12032-011-9880-5] [Cited by in Crossref: 82] [Cited by in F6Publishing: 83] [Article Influence: 8.2] [Reference Citation Analysis]
114 Kohles N, Nagel D, Jüngst D, Durner J, Stieber P, Holdenrieder S. Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy. Tumour Biol. 2012;33:33-40. [PMID: 21931992 DOI: 10.1007/s13277-011-0237-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
115 Carbajo-pescador S, Martín-renedo J, García-palomo A, Tuñón MJ, Mauriz JL, González-gallego J. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells. Journal of Pineal Research 2009;47:330-8. [DOI: 10.1111/j.1600-079x.2009.00719.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
116 Kumar S, Kumari N, Mittal RD, Mohindra S, Ghoshal UC. Association between pro-(IL-8) and anti-inflammatory (IL-10) cytokine variants and their serum levels and H. pylori-related gastric carcinogenesis in northern India. Meta Gene 2015;6:9-16. [PMID: 26380815 DOI: 10.1016/j.mgene.2015.07.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
117 Yeh CN, Wu RC, Cheng CT, Tsai CY, Chang YR, Yeh TS, Wu TH, Lee WC, Chiang KC. HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy. Cancer Manag Res 2018;10:6049-59. [PMID: 30538554 DOI: 10.2147/CMAR.S186931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
118 Lin C, Kuo C, Lu C, Wu M, Huang RS. Elevated Serum Vitamin B 12 Levels in Association With Tumor Markers as the Prognostic Factors Predictive for Poor Survival in Patients With Hepatocellular Carcinoma. Nutrition and Cancer 2010;62:190-7. [DOI: 10.1080/01635580903305334] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
119 Li L, Xu Y, Wang B. Liriodenine induces the apoptosis of human laryngocarcinoma cells via the upregulation of p53 expression. Oncol Lett 2015;9:1121-7. [PMID: 25663867 DOI: 10.3892/ol.2014.2834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
120 Li JZ, Gao W, Lei WB, Zhao J, Chan JY, Wei WI, Ho WK, Wong TS. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma. Oncotarget 2016;7:58218-33. [PMID: 27533461 DOI: 10.18632/oncotarget.11280] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
121 Taioli E, Garza MA, Ahn YO, Bishop DT, Bost J, Budai B, Chen K, Gemignani F, Keku T, Lima CS, Le Marchand L, Matsuo K, Moreno V, Plaschke J, Pufulete M, Thomas SB, Toffoli G, Wolf CR, Moore CG, Little J. Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am J Epidemiol 2009;170:1207-21. [PMID: 19846566 DOI: 10.1093/aje/kwp275] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
122 Jacobs L, van der Vlies E, Ten Bokkel Huinink D, Bloemendal H, Intven M, Smits AB, Weusten BLAM, Siersema PD, van Lelyveld N, Los M. Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged ≥ 70 Years With Locally Advanced Rectal Cancer. Clin Colorectal Cancer 2018;17:179-86. [PMID: 29661620 DOI: 10.1016/j.clcc.2018.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Zhou S, Du R, Wang Z, Shen W, Gao R, Jiang S, Fang Y, Shi Y, Chang A, Liu L, Liu C, Li N, Xiang R. TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma. Cancer Med 2019;8:2325-37. [PMID: 30957973 DOI: 10.1002/cam4.2070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
124 Soundararajan A, Bao A, Phillips WT, McManus LM, Goins BA. Chemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response. Cancer Biother Radiopharm 2011;26:603-14. [PMID: 21834653 DOI: 10.1089/cbr.2010.0948] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
125 Mohanty S, Jensen D. Tumor Markers and Molecular Biology. In: Al Knawy B, Reddy K, Bolondi L, editors. Hepatocellular Carcinoma. CRC Press; 2009. pp. 62-81. [DOI: 10.3109/9780203092880-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
126 Yu Q, Zhang L, Hou K, Li J, Liu S, Huang K, Cheng Y. Relationship between Air Pollutant Exposure and Gynecologic Cancer Risk. Int J Environ Res Public Health 2021;18:5353. [PMID: 34069801 DOI: 10.3390/ijerph18105353] [Reference Citation Analysis]
127 Padrik P, Leppik K, Arak A. Combination therapy with capecitabine and interferon alfa-2A in patients with advanced renal cell carcinoma: A phase II study. Urologic Oncology: Seminars and Original Investigations 2004;22:387-92. [DOI: 10.1016/j.urolonc.2003.11.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
128 Nguyen VT, Amin J, Law MG, Dore GJ. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia. J Gastroenterol Hepatol. 2009;24:436-442. [PMID: 19175834 DOI: 10.1111/j.1440-1746.2008.05577.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
129 Lee C, Peng C, Li R, Chen Y, Tsai H, Hung Y, Chan T, Huang H, Lai T, Wu M. Risk evaluation for the development of cervical intraepithelial neoplasia: Development and validation of risk-scoring schemes: Rrisk-scoring of cervical intraepithelial neoplasia. Int J Cancer 2015;136:340-9. [DOI: 10.1002/ijc.28982] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
130 Sturgis EM, Pytynia KB. After the Smoke Clears: Environmental and Occupational Risks for Carcinoma of the Upper Aerodigestive Tract. The Cancer Journal 2005;11:96-103. [DOI: 10.1097/00130404-200503000-00002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
131 Bello HR, Mahdi ZK, Lui SK, Nandwana SB, Harri PA, Davarpanah AH. Hepatocellular Carcinoma With Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes With Radiology-Pathology Correlation. J Magn Reson Imaging 2021. [PMID: 33682266 DOI: 10.1002/jmri.27553] [Reference Citation Analysis]
132 Wei F, Ba S, Jin M, Ci R, Wang X, E F, Long Z. RNF180 Inhibits Proliferation and Promotes Apoptosis of Colorectal Cancer Through Ubiquitination of WISP1. Front Cell Dev Biol 2020;8:623455. [PMID: 33553163 DOI: 10.3389/fcell.2020.623455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Vauléon E, Mesbah H, Laguerre B, Gédouin D, Lefeuvre-Plesse C, Levêque J, Audrain O, Kerbrat P. Usefulness of chemotherapy beyond the second line for metastatic breast cancer: a therapeutic challenge. Cancer Chemother Pharmacol 2010;66:113-20. [PMID: 19784837 DOI: 10.1007/s00280-009-1141-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
134 Jiang XJ, Song MQ, Xin YN, Gao YQ, Niu ZY, Tian ZB. Endoscopic stenting and concurrent chemoradiotherapy for advanced esophageal cancer: A case-control study. World J Gastroenterol 2012; 18(12): 1404-1409 [PMID: 22493556 DOI: 10.3748/wjg.v18.i12.1404] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
135 Mans DRA, Mohamedradja RN, Hoeblal ARD, Rampadarath R, Joe SSTA, Wong J, Ramautar P, Mahabier R, Vrede MA. Cancer Incidence in Suriname from 1980 through 2000 a Descriptive Study. Tumori 2003;89:368-76. [DOI: 10.1177/030089160308900404] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
136 Mendoza-lorenzo P, Maldonado R, Pacheco R, Méndez A, Piña-sánchez P, Rangel A, Vazquez-ortíz G, Salcedo M. An oligoarray for the detection of human papillomavirus type 16 variants. Int J Gynecol Cancer 2007;17:1083-91. [DOI: 10.1111/j.1525-1438.2007.00832.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
137 Duraipandian S, Zheng W, Ng J, Low JJ, Ilancheran A, Huang Z. In vivo diagnosis of cervical precancer using Raman spectroscopy and genetic algorithm techniques. Analyst 2011;136:4328-36. [PMID: 21869948 DOI: 10.1039/c1an15296c] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
138 McLaughlin JM, Olivo-Marston S, Vitolins MZ, Bittoni M, Reeves KW, Degraffinreid CR, Schwartz SJ, Clinton SK, Paskett ED. Effects of tomato- and soy-rich diets on the IGF-I hormonal network: a crossover study of postmenopausal women at high risk for breast cancer. Cancer Prev Res (Phila) 2011;4:702-10. [PMID: 21430071 DOI: 10.1158/1940-6207.CAPR-10-0329] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
139 Lee J, Jeong DJ, Kim J, Lee S, Park JH, Chang B, Jung SI, Yi L, Han Y, Yang Y. The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma. Mol Cancer. 2010;9:109. [PMID: 20482749 DOI: 10.1186/1476-4598-9-109] [Cited by in Crossref: 91] [Cited by in F6Publishing: 90] [Article Influence: 8.3] [Reference Citation Analysis]
140 Palsdottir HB, Hardarson S, Petursdottir V, Jonsson A, Jonsson E, Sigurdsson MI, Einarsson GV, Gudbjartsson T. Incidental Detection of Renal Cell Carcinoma is an Independent Prognostic Marker: Results of a Long-Term, Whole Population Study. Journal of Urology 2012;187:48-53. [DOI: 10.1016/j.juro.2011.09.025] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
141 Choi SB, Kim KS, Park YN, Choi JS, Lee WJ, Seong J, Han KH, Lee JT. The efficacy of hepatic resection after neoadjuvant transarterial chemoembolization (TACE) and radiation therapy in hepatocellular carcinoma greater than 5 cm in size. J Korean Med Sci 2009;24:242-7. [PMID: 19399265 DOI: 10.3346/jkms.2009.24.2.242] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
142 Ito E, Yip KW, Katz D, Fonseca SB, Hedley DW, Chow S, Xu GW, Wood TE, Bastianutto C, Schimmer AD, Kelley SO, Liu F. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer. Mol Pharmacol 2009;76:969-83. [DOI: 10.1124/mol.109.055277] [Cited by in Crossref: 79] [Cited by in F6Publishing: 61] [Article Influence: 6.6] [Reference Citation Analysis]
143 Tischoff I, Tannapfel A. DNA methylation in hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1741-1748 [PMID: 18350605 DOI: 10.3748/wjg.14.1741] [Cited by in CrossRef: 117] [Cited by in F6Publishing: 110] [Article Influence: 9.0] [Reference Citation Analysis]
144 Kim JH, Park JW, Kim TH, Koh DW, Lee WJ, Kim CM. Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2007;69:813-9. [PMID: 17524569 DOI: 10.1016/j.ijrobp.2007.04.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
145 Zhang H, Lin W, Kannan K, Luo L, Li J, Chao PW, Wang Y, Chen YP, Gu J, Yen L. Aberrant chimeric RNA GOLM1-MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma. Oncotarget 2013;4:2135-43. [PMID: 24243830 DOI: 10.18632/oncotarget.1465] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
146 Abou-Alfa GK. Commentary: Sorafenib -- the end of a long journey in search of systemic therapy for hepatocellular carcinoma, or the beginning? Oncologist. 2009;14:92-94. [PMID: 19144679 DOI: 10.1634/theoncologist.2008-0294] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
147 Gobbo M, Bullo F, Perinetti G, Gatto A, Ottaviani G, Biasotto M, Tirelli G. Diagnostic and therapeutic features associated with modification of quality-of-life's outcomes between one and six months after major surgery for head and neck cancer. Brazilian Journal of Otorhinolaryngology 2016;82:548-57. [DOI: 10.1016/j.bjorl.2015.10.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
148 Zhuang W, Wu XT, Zhou Y, Liu GJ, Wu TX, Yao X, Du L, Wei ML. Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions and gastric cancer. Dig Dis Sci. 2009;54:1379-1385. [PMID: 738222 DOI: 10.1007/s10620-008-0511-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
149 Hassan Saad R, Halawa SM, Zidan AM, Emara NM, Abdelghany OA. Malignant transformation of oral squamous cell papilloma: a case report. Int J Surg Case Rep 2020;75:348-51. [PMID: 32980707 DOI: 10.1016/j.ijscr.2020.09.064] [Reference Citation Analysis]
150 Buijs M, Vossen JA, Frangakis C, Hong K, Georgiades CS, Chen Y, Liapi E, Geschwind JF. Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience. Radiology 2008;249:346-54. [PMID: 18796686 DOI: 10.1148/radiol.2483071902] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
151 Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, Gupta SD, Ralhan R. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci 2007;81:280-7. [PMID: 17599361 DOI: 10.1016/j.lfs.2007.05.012] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 5.4] [Reference Citation Analysis]
152 Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593-608. [PMID: 23419824 DOI: 10.1016/j.jhep.2012.12.005] [Cited by in Crossref: 744] [Cited by in F6Publishing: 666] [Article Influence: 93.0] [Reference Citation Analysis]
153 Senthilnathan S, Memon K, Lewandowski RJ, Kulik L, Mulcahy MF, Riaz A, Miller FH, Yaghmai V, Nikolaidis P, Wang E. Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients. Hepatology. 2012;55:1432-1442. [PMID: 22109811 DOI: 10.1002/hep.24812] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
154 Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, Chen Y, Park O, Chang J, Simpson RM. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA. 2010;107:1431-1436. [PMID: 20080598 DOI: 10.1073/pnas.0911409107] [Cited by in Crossref: 364] [Cited by in F6Publishing: 357] [Article Influence: 33.1] [Reference Citation Analysis]
155 Brink AATP, Zielinski GD, Steenbergen RDM, Snijders PJF, Meijer CJLM. Clinical relevance of human papillomavirus testing in cytopathology. Cytopathology 2005;16:7-12. [DOI: 10.1111/j.1365-2303.2004.00227.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
156 Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519-524. [PMID: 11870363 DOI: 10.1053/jhep.2002.32089] [Cited by in Crossref: 801] [Cited by in F6Publishing: 753] [Article Influence: 42.2] [Reference Citation Analysis]
157 Huan H, Wen X, Chen X, Wu L, Liu W, Habib NA, Bie P, Xia F. C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT. PLoS One 2016;11:e0153117. [PMID: 27050434 DOI: 10.1371/journal.pone.0153117] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
158 Wu CS, Chen YJ, Chen JJ, Shieh JJ, Huang CH, Lin PS, Chang GC, Chang JT, Lin CC. Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo. Evid Based Complement Alternat Med 2012;2012:818261. [PMID: 21760828 DOI: 10.1155/2012/818261] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
159 Maher DM, Bell MC, O'donnell EA, Gupta BK, Jaggi M, Chauhan SC. Curcumin suppresses human papillomavirus oncoproteins, restores p53, rb, and ptpn13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7: CURCUMIN INHIBITS BaP INDUCED HPV ONCOGENES. Mol Carcinog 2011;50:47-57. [DOI: 10.1002/mc.20695] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
160 Nakajima K, Yamanaka T, Nakatsuka A, Haruyuki T, Fujimori M, Sugino Y, Matsushita N, Sakuma H, Isaji S, Takei Y, Yamakado K. Clinical utility of radiofrequency ablation following transarterial injection of miriplatin-iodized oil suspension in small hepatocellular carcinoma. Jpn J Radiol 2016;34:640-6. [PMID: 27455985 DOI: 10.1007/s11604-016-0567-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
161 Mohammadian M, Zeynali S, Azarbaijani AF, Khadem Ansari MH, Kheradmand F. Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines. Res Pharm Sci 2017;12:517-25. [PMID: 29204180 DOI: 10.4103/1735-5362.217432] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
162 Lee DH, Lee JM, Yu MH, Hur BY, Yi N, Lee K, Suh K, Yoon J, Kim YJ, Lee J, Yu SJ, Han JK. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC. Eur Radiol 2019;29:3122-31. [DOI: 10.1007/s00330-018-5941-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
163 Tripathy CB, Roy N. Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer. Head Neck 2006;28:217-24. [PMID: 16302194 DOI: 10.1002/hed.20295] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
164 Hiraki A, Matsuo K, Wakai K, Suzuki T, Hasegawa Y, Tajima K. Gene-gene and gene-environment interactions between alcohol drinking habit and polymorphisms in alcohol-metabolizing enzyme genes and the risk of head and neck cancer in Japan. Cancer Sci 2007;98:1087-91. [PMID: 17489985 DOI: 10.1111/j.1349-7006.2007.00505.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
165 Yu HC, Hung MH, Chen YL, Chu PY, Wang CY, Chao TT, Liu CY, Shiau CW, Chen KF. Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A. Cell Death Dis 2014;5:e1359. [PMID: 25077545 DOI: 10.1038/cddis.2014.325] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
166 Behari J, Zeng G, Otruba W, Thompson MD, Muller P, Micsenyi A, Sekhon SS, Leoni L, Monga SP. R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells. J Hepatol. 2007;46:849-857. [PMID: 17275129 DOI: 10.1016/j.jhep.2006.11.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
167 Zhang T, Wang W, Li Y, Jin J, Wang S, Song Y, Liu Y. Inter- and intrafractional setup errors and baseline shifts of fiducial markers in patients with liver tumors receiving free-breathing postoperative radiation analyzed by cone-beam computed tomography. J Appl Clin Med Phys 2014;15:4914. [PMID: 25493517 DOI: 10.1120/jacmp.v15i6.4914] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
168 Ward DG, Cheng Y, N'Kontchou G, Thar TT, Barget N, Wei W, Billingham LJ, Martin A, Beaugrand M, Johnson PJ. Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. Br J Cancer. 2006;94:287-292. [PMID: 16404431 DOI: 10.1038/sj.bjc.6602923] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
169 Lin G, Chen C, Yin F, Yang C, Tian J, Chen T, Xu G, He C, Lin MC, Wang J, Lu F, Wang X, Yong K. Biodegradable nanoparticles as siRNA carriers for in vivo gene silencing and pancreatic cancer therapy. J Mater Chem B 2017;5:3327-37. [DOI: 10.1039/c6tb03116a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
170 Uno K, Iijima K, Hatta W, Koike T, Abe Y, Asano N, Kusaka G, Shimosegawa T. Direct measurement of gastroesophageal reflux episodes in patients with squamous cell carcinoma by 24-h pH-impedance monitoring. Am J Gastroenterol 2011;106:1923-9. [PMID: 21931379 DOI: 10.1038/ajg.2011.282] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
171 Kimura H, Kasahara K, Shibata K, Sone T, Yoshimoto A, Kita T, Ichikawa Y, Waseda Y, Watanabe K, Shiarasaki H, Ishiura Y, Mizuguchi M, Nakatsumi Y, Kashii T, Kobayashi M, Kunitoh H, Tamura T, Nishio K, Fujimura M, Nakao S. EGFR Mutation of Tumor and Serum in Gefitinib-Treated Patients with Chemotherapy-Naive Non–small Cell Lung Cancer. Journal of Thoracic Oncology 2006;1:260-7. [DOI: 10.1016/s1556-0864(15)31577-x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
172 Park ES, Shum JW, Bui TG, Bell RB, Dierks EJ. Robotic Surgery. Oral and Maxillofacial Surgery Clinics of North America 2013;25:49-59. [DOI: 10.1016/j.coms.2012.11.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
173 Xiao YS, Tang ZY, Fan J, Zhou J, Wu ZQ, Sun QM, Xue Q, Zhao Y, Liu YK, Ye SL. Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice. J Cancer Res Clin Oncol. 2004;130:546-550. [PMID: 15071737 DOI: 10.1007/s00432-004-0565-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
174 Lu C, Xu CF, Wan XY, Zhu HT, Yu CH, Li YM. Screening for pancreatic cancer in familial high-risk individuals: A systematic review. World J Gastroenterol 2015; 21(28): 8678-8686 [PMID: 26229410 DOI: 10.3748/wjg.v21.i28.8678] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 32] [Article Influence: 6.7] [Reference Citation Analysis]
175 van Sprundel RG, van den Ingh TS, Desmet VJ, Katoonizadeh A, Penning LC, Rothuizen J, Roskams T, Spee B. Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours. Comp Hepatol. 2010;9:4. [PMID: 20167095 DOI: 10.1186/1476-5926-9-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
176 Tahara T, Arisawa T, Shibata T, Nakamura M, Wang F, Maruyama N, Kamiya Y, Nakamura M, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Hirata I, Nakano H. Influence of peroxisome proliferator-activated receptor (PPAR)gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese. Dig Dis Sci 2008;53:614-21. [PMID: 17763950 DOI: 10.1007/s10620-007-9944-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
177 Chung MT, Lai HC, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Liu HS, Chu DW, Lin YW. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol. 2009;112:646-653. [PMID: 19095296 DOI: 10.1016/j.ygyno.2008.10.026] [Cited by in Crossref: 97] [Cited by in F6Publishing: 91] [Article Influence: 7.5] [Reference Citation Analysis]
178 Shin D, Kim TH, Park SY, Kwak J, Moon SH, Yoon M, Lee SB, Park S, Shin KH, Kim DY, Cho KH, Park J, Kim C. Influence of Lipiodol Agent on Proton Beam Range in Radiotherapy Planning Using Computed Tomography for Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2008;72:687-94. [DOI: 10.1016/j.ijrobp.2008.01.059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
179 Dong C, Yoon YH, Chen CM, Yi HY. Heavy alcohol use and premature death from hepatocellular carcinoma in the United States, 1999-2006. J Stud Alcohol Drugs 2011;72:892-902. [PMID: 22051203 DOI: 10.15288/jsad.2011.72.892] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
180 Mcnally ME, Martinez A, Khabiri H, Guy G, Michaels AJ, Hanje J, Kirkpatrick R, Bloomston M, Schmidt CR. Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Ann Surg Oncol 2013;20:923-8. [DOI: 10.1245/s10434-012-2639-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
181 Chen J, Xu X, Wu J, Ling Q, Wang K, Wang W, Zhang M, Shen Y, Zhou L, Xie H. The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma. PLoS One. 2014;9:e93128. [PMID: 24676010 DOI: 10.1371/journal.pone.0093128] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
182 Daley EM, Vamos CA, Thompson EL, Zimet GD, Rosberger Z, Merrell L, Kline NS. The feminization of HPV: How science, politics, economics and gender norms shaped U.S. HPV vaccine implementation. Papillomavirus Res 2017;3:142-8. [PMID: 28720448 DOI: 10.1016/j.pvr.2017.04.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
183 Chen X, Wu F, Liu Y, Lou J, Zhu B, Zou L, Chen W, Gong J, Wang Y, Zhong R. The contribution of serum hepatitis B virus load in the carcinogenesis and prognosis of hepatocellular carcinoma: evidence from two meta-analyses. Oncotarget 2016;7:49299-309. [PMID: 27384478 DOI: 10.18632/oncotarget.10335] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
184 Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, Campisi G. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988–2007). Annals of Oncology 2008;19:1681-90. [DOI: 10.1093/annonc/mdn372] [Cited by in Crossref: 201] [Cited by in F6Publishing: 176] [Article Influence: 15.5] [Reference Citation Analysis]
185 Choi SJ, Kim J, Seo J, Kim HS, Lee JM, Park H. Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization. Eur Radiol 2016;26:225-34. [PMID: 25991485 DOI: 10.1007/s00330-015-3825-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
186 Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology. 2005;41:722-730. [PMID: 15791620 DOI: 10.1002/hep.20644] [Cited by in Crossref: 192] [Cited by in F6Publishing: 185] [Article Influence: 12.0] [Reference Citation Analysis]
187 Jeng KS, Sheen IS, Jeng WJ, Yu MC, Tsai HH, Chang FY, Su JC. Blockade of the sonic hedgehog pathway effectively inhibits the growth of hepatoma in mice: An in vivo study. Oncol Lett. 2012;4:1158-1162. [PMID: 23205113 DOI: 10.3892/ol.2012.935] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
188 Wu S, Zheng Q, Xing X, Dong Y, Wang Y, You Y, Chen R, Hu C, Chen J, Gao D, Zhao Y, Wang Z, Xue T, Ren Z, Cui J. Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation. J Exp Clin Cancer Res 2018;37:99. [PMID: 29728125 DOI: 10.1186/s13046-018-0761-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 13.0] [Reference Citation Analysis]
189 Bray F, Loos AH, Tognazzo S, La Vecchia C. Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer 2005;113:977-90. [DOI: 10.1002/ijc.20649] [Cited by in Crossref: 92] [Cited by in F6Publishing: 82] [Article Influence: 5.4] [Reference Citation Analysis]
190 Kloog I, Stevens RG, Haim A, Portnov BA. Nighttime light level co-distributes with breast cancer incidence worldwide. Cancer Causes Control 2010;21:2059-68. [PMID: 20680434 DOI: 10.1007/s10552-010-9624-4] [Cited by in Crossref: 111] [Cited by in F6Publishing: 87] [Article Influence: 10.1] [Reference Citation Analysis]
191 Lei WY, Hsiung SC, Wen SH, Hsieh CH, Chen CL, Wallace CG, Chang CC, Liao SK. Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell Lines. J Immunol Res 2018;2018:8363265. [PMID: 30648121 DOI: 10.1155/2018/8363265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Dimitroulopoulos D, Xinopoulos D, Tsamakidis K, Zisimopoulos A, Andriotis E, Panagiotakos D, Fotopoulou A, Chrysohoou C, Bazinis A, Daskalopoulou D, Paraskevas E. Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: Randomized placebo-controlled trial. World J Gastroenterol 2007; 13(23): 3164-3170 [PMID: 17589893 DOI: 10.3748/wjg.v13.i23.3164] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
193 Chen X, Zhang L, Chang Y, Shen T, Wang L, Zhuang H, Lu F. Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a Han Chinese population. Int J Biol Markers. 2011;26:181-187. [PMID: 21928250 DOI: 10.5301/jbm.2011.8580] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
194 Roayaie S, Llovet JM. Liver Transplantation for Hepatocellular Carcinoma: Is Expansion of Criteria Justified? Clinics in Liver Disease 2005;9:315-28. [DOI: 10.1016/j.cld.2004.12.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
195 Tipirisetti NR, Govatati S, Pullari P, Malempati S, Thupurani MK, Perugu S, Guruvaiah P, Rao K L, Digumarti RR, Nallanchakravarthula V, Bhanoori M, Satti V. Mitochondrial control region alterations and breast cancer risk: a study in South Indian population. PLoS One 2014;9:e85363. [PMID: 24497926 DOI: 10.1371/journal.pone.0085363] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
196 Baldan A, Marino D, De Giorgio M, Angonese C, Cillo U, D'alessandro A, Masotto A, Massani M, Mazzucco M, Miola E, Neri D, Paccagnella D, Pivetta G, Stellato A, Tommasi L, Tremolada F, Tufano A, Zanus G, Farinati F; ON BEHALF OF GENE – GRUPPO EPATOCARCINOMA NORD-EST1. Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma. Aliment Pharmacol Ther 2006;24:1495-501. [DOI: 10.1111/j.1365-2036.2006.03136.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
197 Xu N, Shao MM, Zhang HT, Jin MS, Dong Y, Ou RJ, Wang HM, Shi AP. Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer. Cancer Epidemiol 2015;39:375-81. [PMID: 25843691 DOI: 10.1016/j.canep.2015.03.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
198 Wang GY, Lv QH, Dong Q, Xu RZ, Dong QH. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice. J Asian Nat Prod Res. 2009;11:219-228. [PMID: 19408145 DOI: 10.1080/10286020802675076] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
199 Wu M, Lian B, Deng Y, Feng Z, Zhong C, Wu W, Huang Y, Wang L, Zu C, Zhao X. Resveratrol-loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles: Preparation, characterization, and targeting effect on liver tumors. J Biomater Appl 2017;32:191-205. [PMID: 28610486 DOI: 10.1177/0885328217713357] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
200 Chang P, Chi C, Chau G, Li F, Tsai Y, Wu J, Wu Lee Y. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene 2006;25:1991-2003. [DOI: 10.1038/sj.onc.1209239] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 6.0] [Reference Citation Analysis]
201 Benard A, Desmedt C, Smolina M, Szternfeld P, Verdonck M, Rouas G, Kheddoumi N, Rothé F, Larsimont D, Sotiriou C, Goormaghtigh E. Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment. Analyst 2014;139:1044-56. [PMID: 24418921 DOI: 10.1039/c3an01454a] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
202 Hersoug LG, Arnau J. A built-in co-carcinogenic effect due to viruses involved in latent or persistent infections. Med Hypotheses 2007;68:1001-8. [PMID: 17125934 DOI: 10.1016/j.mehy.2006.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
203 Oquiñena S, Iñarrairaegui M, Vila JJ, Alegre F, Zozaya JM, Sangro B. Spontaneous regression of hepatocellular carcinoma: three case reports and a categorized review of the literature. Dig Dis Sci 2009;54:1147-53. [PMID: 18716866 DOI: 10.1007/s10620-008-0447-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
204 Beevi SS, Rasheed MH, Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clinica Chimica Acta 2007;375:119-23. [DOI: 10.1016/j.cca.2006.06.028] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
205 Liu Z, Li G, Wei S, Niu J, Wang LE, Sturgis EM, Wei Q. Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2010;31:1977-81. [PMID: 20802237 DOI: 10.1093/carcin/bgq179] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
206 McKillop IH, Moran DM, Jin X, Koniaris LG. Molecular pathogenesis of hepatocellular carcinoma. J Surg Res. 2006;136:125-135. [PMID: 17023002 DOI: 10.1016/j.jss.2006.04.013] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
207 Lu XM, Yang T, Xu SY, Wen H, Wang X, Ren ZH, Zhang Y, Wang W. Glutathione-S-transferase M1 polymorphisms on the susceptibility to esophageal cancer among three Chinese minorities: Kazakh, Tajik and Uygur. World J Gastroenterol 2006; 12(48): 7758-7761 [PMID: 17203516 DOI: 10.3748/wjg.v12.i48.7758] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
208 Johnson AH, Frierson HF, Zaika A, Powell SM, Roche J, Crowe S, Moskaluk CA, El-Rifai W. Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am J Pathol. 2005;167:577-584. [PMID: 16049341 DOI: 10.1016/s0002-9440(10)62999-9] [Cited by in Crossref: 76] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
209 Altomonte J, Marozin S, De Toni EN, Rizzani A, Esposito I, Steiger K, Feuchtinger A, Hellerbrand C, Schmid RM, Ebert O. Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis. Mol Ther 2013;21:2032-42. [PMID: 23939023 DOI: 10.1038/mt.2013.181] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
210 Jerjes W, Upile T, Hamdoon Z, Mosse CA, Akram S, Hopper C. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:180-7. [PMID: 21232996 DOI: 10.1016/j.tripleo.2010.09.078] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
211 Porter J, Ding Y, Hale SJM, Perrins RD, Robinson A, Mazanetz MP, Wu Y, Ma Y, Conlon K, Coulter T. A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinoma. Bioorg Med Chem Lett 2020;30:127634. [PMID: 33148516 DOI: 10.1016/j.bmcl.2020.127634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Zhang XF, Yin ZF, Wang K, Zhang ZQ, Qian HH, Shi LH. Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance. Hepatobiliary Pancreat Dis Int. 2012;11:618-623. [PMID: 23232633 DOI: 10.1016/s1499-3872(12)60234-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
213 Lin G, Hu R, Law W, Chen C, Wang Y, Li Chin H, Nguyen QT, Lai CK, Yoon HS, Wang X, Xu G, Ye L, Cheng C, Yong K. Biodegradable Nanocapsules as siRNA Carriers for Mutant K-Ras Gene Silencing of Human Pancreatic Carcinoma Cells. Small 2013;9:2757-63. [DOI: 10.1002/smll.201201716] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
214 Tovar JM, Bazaldua OV, Vargas L, Reile E. Human Papillomavirus, Cervical Cancer, and the Vaccines. Postgraduate Medicine 2015;120:79-84. [DOI: 10.3810/pgm.2008.07.1794] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
215 Rossi A, Maione P, Gridelli C. Cetuximab in advanced non-small cell lung cancer. Crit Rev Oncol Hematol 2006;59:139-49. [PMID: 16806963 DOI: 10.1016/j.critrevonc.2006.02.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
216 Fhager A, Persson M. Comparison of two image reconstruction algorithms for microwave tomography: TWO ALGORITHMS FOR MICROWAVE TOMOGRAPHY. Radio Sci 2005;40:n/a-n/a. [DOI: 10.1029/2004rs003105] [Cited by in Crossref: 19] [Article Influence: 1.2] [Reference Citation Analysis]
217 Milacic V, Dou QP. The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy. Coord Chem Rev 2009;253:1649-60. [PMID: 20047011 DOI: 10.1016/j.ccr.2009.01.032] [Cited by in Crossref: 113] [Cited by in F6Publishing: 102] [Article Influence: 9.4] [Reference Citation Analysis]
218 Lee WC, Wu TJ, Chou HS, Yu MC, Hsu PY, Hsu HY, Wang CC. The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery. 2012;151:213-222. [PMID: 21975289 DOI: 10.1016/j.surg.2011.07.029] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
219 Liu W, Han B, Sun B, Gao Y, Huang Y, Hu M. Overexpression of Interleukin-18 Induces Growth Inhibition, Apoptosis and Gene Expression Changes in a Human Tongue Squamous Cell Carcinoma Cell Line. J Int Med Res 2012;40:537-44. [DOI: 10.1177/147323001204000215] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
220 Akinremi TO, Ogo CN, Olutunde AO. Review of prostate cancer research in Nigeria. Infect Agent Cancer 2011;6 Suppl 2:S8. [PMID: 21992456 DOI: 10.1186/1750-9378-6-S2-S8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
221 Lambert B, Praet M, Vanlangenhove P, Troisi R, de Hemptinne B, Gemmel F, Van Vlierberghe H, Van de Wiele C. Radiolabeled lipiodol therapy for hepatocellular carcinoma in patients awaiting liver transplantation: pathology of the explant livers and clinical outcome. Cancer Biother Radiopharm. 2005;20:209-214. [PMID: 15869457 DOI: 10.1089/cbr.2005.20.209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
222 Kim S, Arduino JM, Roberts CC, Marsico M, Liaw K, Skjeldestad FE. Incidence and Predictors of Human Papillomavirus-6, -11, -16, and -18 Infection in Young Norwegian Women. Sexually Transmitted Diseases 2011;38:587-97. [DOI: 10.1097/olq.0b013e31820a9324] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
223 Xia X, Liu K, Zhang H, Shang Z. Correlation between CCR 7 expression and lymph node metastatic potential of human tongue carcinoma. Oral Dis 2015;21:123-31. [DOI: 10.1111/odi.12228] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
224 Kakizoe T. Development and progression of urothelial carcinoma. Cancer Sci. 2006;97:821-828. [PMID: 16822297 DOI: 10.1111/j.1349-7006.2006.00264.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
225 Javaraiah RK, David CM, Namitha J, Tiwari R, Benakanal P. Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity. South Asian J Cancer 2020;9:93-8. [PMID: 33354552 DOI: 10.1055/s-0040-1721174] [Reference Citation Analysis]
226 Saverio Ferrari F, Stella A, Pasquinucci P, Vigni F, Civeli L, Pieraccini M, Magnolfi F. Treatment of small hepatocellular carcinoma: a comparison of techniques and long-term results: . European Journal of Gastroenterology & Hepatology 2006;18:659-72. [DOI: 10.1097/00042737-200606000-00014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
227 Chitapanarux I, Lorvidhaya V, Tharavichitkul E, Mayurasakorn S, Sittitrai P, Pattarasakulchai T, Tananuwat R, Srivanitchapoom C. A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer. Auris Nasus Larynx 2011;38:108-13. [DOI: 10.1016/j.anl.2010.05.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
228 Feng X, Pai M, Mizandari M, Chikovani T, Spalding D, Jiao L, Habib N. Towards the optimization of management of hepatocellular carcinoma. Front Med 2011;5:271-6. [DOI: 10.1007/s11684-011-0148-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
229 Pandey S, Mittal RD, Srivastava M, Srivastava K, Singh S, Srivastava S, Mittal B. Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecol Oncol. 2009;114:501-505. [PMID: 19541348 DOI: 10.1016/j.ygyno.2009.05.032] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 6.1] [Reference Citation Analysis]
230 Liu Y, Song N, Ren K, Meng S, Xie Y, Long Q, Chen X, Zhao X. Expression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development. PLoS One 2013;8:e78417. [PMID: 24223801 DOI: 10.1371/journal.pone.0078417] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
231 Goel A, Gandhi G, Batra S, Bhambhani S, Zutshi V, Sachdeva P. Visual inspection of the cervix with acetic acid for cervical intraepithelial lesions. Int J Gynaecol Obstet. 2005;88:25-30. [PMID: 15617701 DOI: 10.1016/j.ijgo.2004.09.018] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
232 Hsieh CH, Hsu YJ, Chang CC, Liu HC, Chuang KL, Chuang CK, Pang ST, Hasumi K, Ferrone S, Liao SK. Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes. Cancer Immunol Immunother 2009;58:395-408. [PMID: 18704411 DOI: 10.1007/s00262-008-0565-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
233 Breijer MC, Timmermans A, van Doorn HC, Mol BW, Opmeer BC. Diagnostic strategies for postmenopausal bleeding. Obstet Gynecol Int 2010;2010:850812. [PMID: 20169169 DOI: 10.1155/2010/850812] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
234 Leung WK, To K, Man EPS, Chan MWY, Hui AJ, Ng SSM, Lau JYW, Sung JJY. Detection of Hypermethylated DNA or Cyclooxygenase-2 Messenger RNA in Fecal Samples of Patients With Colorectal Cancer or Polyps. Am J Gastroenterology 2007;102:1070-6. [DOI: 10.1111/j.1572-0241.2007.01108.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
235 Gridelli C, Maione P, Del Gaizo F, Colantuoni G, Guerriero C, Ferrara C, Nicolella D, Comunale D, De Vita A, Rossi A. Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer. Oncologist. 2007;12:191-200. [PMID: 17296815 DOI: 10.1634/theoncologist.12-2-191] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 5.6] [Reference Citation Analysis]
236 Ng SK, Neo SY, Yap YW, Karuturi RK, Loh ES, Liau KH, Ren EC. Ablation of phosphoinositide-3-kinase class II alpha suppresses hepatoma cell proliferation. Biochem Biophys Res Commun 2009;387:310-5. [PMID: 19591801 DOI: 10.1016/j.bbrc.2009.07.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
237 Bozas G, Dimopoulos MA, Kastritis E, Efstathiou E, Koutsoukou V, Rodolakis A, Vlahos G, Voulgaris Z, Papageorgiou T, Gika D, Papadimitriou C, Bamias A. Young Age Is Associated with Favorable Characteristics but Is Not an Independent Prognostic Factor in Patients with Epithelial Ovarian Cancer: A Single Institution Experience. Oncology 2006;70:265-72. [DOI: 10.1159/000094889] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
238 Ruan Y, Sun L, Hao Y, Wang L, Xu J, Zhang W, Xie J, Guo L, Zhou L, Yun X, Zhu H, Shen A, Gu J. Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma. J Clin Invest 2012;122:2554-66. [PMID: 22653060 DOI: 10.1172/JCI58488] [Cited by in Crossref: 83] [Cited by in F6Publishing: 52] [Article Influence: 9.2] [Reference Citation Analysis]
239 Gao J, Jia WD, Li JS, Wang W, Xu GL, Ma JL, Ge YS, Yu JH, Ren WH, Liu WB, Zhang CH. Combined inhibitory effects of celecoxib and fluvastatin on the growth of human hepatocellular carcinoma xenografts in nude mice. J Int Med Res 2010;38:1413-27. [PMID: 20926014 DOI: 10.1177/147323001003800423] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
240 Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SSV, Das BC. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res Treat 2004;88:177-86. [DOI: 10.1007/s10549-004-0593-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
241 Hu L, Xue F, Li Y, Shao M, Sun Y, Wei G. A long-term follow-up and comprehensive observation of risk and prognosis factors of recurrence and survival after resection of hepatocellular carcinoma. Cell Biochem Biophys 2014;69:421-31. [PMID: 24728944 DOI: 10.1007/s12013-013-9813-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
242 Tokuhisa Y, Iizuka N, Sakaida I, Moribe T, Fujita N, Miura T, Tamatsukuri S, Ishitsuka H, Uchida K, Terai S, Sakamoto K, Tamesa T, Oka M. Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma. Br J Cancer 2007;97:1399-403. [PMID: 17940509 DOI: 10.1038/sj.bjc.6604034] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
243 Guo-Qing P, Yuan Y, Cai-Gao Z, Hongling Y, Gonghua H, Yan T. A study of association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma. J Exp Clin Cancer Res 2010;29:129. [PMID: 20846459 DOI: 10.1186/1756-9966-29-129] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
244 Menon AG, Tollenaar RA, van de Velde CJ, Putter H, Janssen-van Rhijn CM, Keijzer R, Fleuren GJ, Kuppen PJ. p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases. Clin Exp Metastasis 2004;21:79-85. [PMID: 15065606 DOI: 10.1023/b:clin.0000017206.08931.42] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
245 Belkhiri A, El-Rifai W. Advances in targeted therapies and new promising targets in esophageal cancer. Oncotarget 2015;6:1348-58. [PMID: 25593196 DOI: 10.18632/oncotarget.2752] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
246 Gray J, Chattopadhyay D, Beale GS, Patman GL, Miele L, King BP, Stewart S, Hudson M, Day CP, Manas DM. A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. BMC Cancer. 2009;9:271. [PMID: 19656391 DOI: 10.1186/1471-2407-9-271] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
247 Ludwig H, Van Belle S, Barrett-lee P, Birgegård G, Bokemeyer C, Gascón P, Kosmidis P, Krzakowski M, Nortier J, Olmi P, Schneider M, Schrijvers D. The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. European Journal of Cancer 2004;40:2293-306. [DOI: 10.1016/j.ejca.2004.06.019] [Cited by in Crossref: 537] [Cited by in F6Publishing: 402] [Article Influence: 31.6] [Reference Citation Analysis]
248 王静, 王蔚虹, 李江, 刘芳勋. 阿司匹林对幽门螺杆菌定植的影响. 世界华人消化杂志 2009; 17(9): 854-861 [DOI: 10.11569/wcjd.v17.i9.854] [Reference Citation Analysis]
249 Song MJ, Bae SH, Yoo IR, Park CH, Jang JW, Chun HJ, Choi BG, Lee HG, Choi JY, Yoon SK. Predictive value of 18F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma. World J Gastroenterol 2012; 18(25): 3215-3222 [PMID: 22783045 DOI: 10.3748/wjg.v18.i25.3215] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
250 Felizardo RJ, Câmara NO. Hepatocellular carcinoma and food contamination: Ochratoxin A as a great prompter. World J Gastroenterol 2013; 19(24): 3723-3725 [PMID: 23840111 DOI: 10.3748/wjg.v19.i24.3723] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
251 Kono S, Chen K. Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci. 2005;96:535-542. [PMID: 16128738 DOI: 10.1111/j.1349-7006.2005.00090.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 4.6] [Reference Citation Analysis]
252 Tietze LF, Krewer B. Antibody-Directed Enzyme Prodrug Therapy: A Promising Approach for a Selective Treatment of Cancer Based on Prodrugs and Monoclonal Antibodies. Chemical Biology & Drug Design 2009;74:205-11. [DOI: 10.1111/j.1747-0285.2009.00856.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
253 Dihal AA, Woutersen RA, van Ommen B, Rietjens IM, Stierum RH. Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2. Cancer Lett 2006;238:248-59. [PMID: 16129554 DOI: 10.1016/j.canlet.2005.07.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
254 Choi JY, Kim MJ, Park YN, Lee JM, Yoo SK, Rha SY, Seok JY. Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics. AJR Am J Roentgenol. 2011;197:399-405. [PMID: 21785086 DOI: 10.2214/ajr.10.5439] [Cited by in Crossref: 41] [Cited by in F6Publishing: 17] [Article Influence: 4.1] [Reference Citation Analysis]
255 Mosolits S, Ullenhag G, Mellstedt H. Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results. Ann Oncol 2005;16:847-62. [PMID: 15829493 DOI: 10.1093/annonc/mdi192] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
256 Sauvan M, Pourcelot A, Fournet S, Fernandez H, Capmas P. Office hysteroscopy for postmenopausal women: Feasibility and correlation with transvaginal ultrasound. Journal of Gynecology Obstetrics and Human Reproduction 2018;47:505-10. [DOI: 10.1016/j.jogoh.2018.08.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Roberts NJ, Klein AP. Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer. Cancer Lett 2013;340:227-33. [PMID: 23196058 DOI: 10.1016/j.canlet.2012.11.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
258 Altomonte J, Muñoz-Álvarez KA, Shinozaki K, Baumgartner C, Kaissis G, Braren R, Ebert O. Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats. J Vis Exp 2016. [PMID: 27167921 DOI: 10.3791/53757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
259 Santos RCS, Dias RS, Giordani AJ, Segreto RA, Segreto HRC. Mucosite em pacientes portadores de câncer de cabeça e pescoço submetidos à radioquimioterapia. Rev esc enferm USP 2011;45:1338-44. [DOI: 10.1590/s0080-62342011000600009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
260 Chauhan R, Singh J, Solanki PR, Basu T, O’kennedy R, Malhotra B. Electrochemical piezoelectric reusable immunosensor for aflatoxin B1 detection. Biochemical Engineering Journal 2015;103:103-13. [DOI: 10.1016/j.bej.2015.07.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
261 Yeh CT, Kuo CJ, Lai MW, Chen TC, Lin CY, Yeh TS, Lee WC. CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection. BMC Cancer. 2009;9:324. [PMID: 19744348 DOI: 10.1186/1471-2407-9-324] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
262 Vrdoljak E, Torday L, Sella A, Leyman S, Bavbek S, Kharkevich G, Mardiak J, Szczylik C, Znaor A, Wilking N. Insights into cancer surveillance in Central and Eastern Europe, Israel and Turkey. Eur J Cancer Care (Engl) 2015;24:99-110. [PMID: 24661376 DOI: 10.1111/ecc.12149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
263 Chen C, Ba Y, Li D, Du X, Lia X, Yang H, An J, Xing J, Yang H, Dong G, Guo X. Genetic variations of mitochondrial genome modify risk and prognosis of hepatocellular carcinoma patients. Clin Res Hepatol Gastroenterol 2017;41:378-85. [PMID: 28215537 DOI: 10.1016/j.clinre.2016.12.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
264 Tu HF, Lin SC, Chang KW. MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance. Curr Opin Otolaryngol Head Neck Surg 2013;21:104-11. [PMID: 23340306 DOI: 10.1097/MOO.0b013e32835e1d6e] [Cited by in Crossref: 65] [Cited by in F6Publishing: 32] [Article Influence: 8.1] [Reference Citation Analysis]
265 Galvão DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol 2005;23:899-909. [PMID: 15681536 DOI: 10.1200/JCO.2005.06.085] [Cited by in Crossref: 367] [Cited by in F6Publishing: 138] [Article Influence: 22.9] [Reference Citation Analysis]
266 Prior JO, Barghouth G, Delaloye JF, Leyvraz S, Bischof Delaloye A. The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer. Nucl Med Commun 2003;24:29-36. [PMID: 12501017 DOI: 10.1097/00006231-200301000-00012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
267 Avella DM, Kimchi ET, Donahue RN, Tagaram HR, McLaughlin PJ, Zagon IS, Staveley-O'Carroll KF. The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer. Am J Physiol Regul Integr Comp Physiol 2010;298:R459-66. [PMID: 19923357 DOI: 10.1152/ajpregu.00646.2009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
268 Schettino C, Bareschino MA, Ricci V, Ciardiello F. Erlotinib: an EGF receptor tyrosine kinase inhibitor in non-small-cell lung cancer treatment. Expert Rev Respir Med. 2008;2:167-178. [PMID: 20477246 DOI: 10.1586/17476348.2.2.167] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
269 Bagi CM, Andresen CJ. Models of hepatocellular carcinoma and biomarker strategy. Cancers (Basel) 2010;2:1441-52. [PMID: 24281167 DOI: 10.3390/cancers2031441] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
270 Hatayama Y, Nakamura T, Suzuki M, Azami Y, Ono T, Yabuuchi T, Hayashi Y, Kimura K, Hirose K, Wada H, Hareyama M, Kikuchi Y, Takai Y. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer. Clinical Lung Cancer 2016;17:427-32. [DOI: 10.1016/j.cllc.2015.11.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
271 Gillson J, Ramaswamy Y, Singh G, Gorfe AA, Pavlakis N, Samra J, Mittal A, Sahni S. Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy? Cancers (Basel). 2020;12. [PMID: 32456277 DOI: 10.3390/cancers12051341] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
272 Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485-91. [PMID: 19224838 DOI: 10.1200/JCO.2008.20.7753] [Cited by in Crossref: 1121] [Cited by in F6Publishing: 613] [Article Influence: 93.4] [Reference Citation Analysis]
273 Chen WS, Liu LC, Yen CJ, Chen YJ, Chen JY, Ho CY, Liu SH, Chen CC, Huang WC. Nuclear IKKα mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression. Oncotarget 2016;7:56309-23. [PMID: 27409165 DOI: 10.18632/oncotarget.10462] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
274 Rao S, Cunningham D, Price T, Hill ME, Ross PJ, Tebbutt N, Norman AR, Oates J, Shellito P. Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer. Br J Cancer 2004;91:839-43. [PMID: 15266319 DOI: 10.1038/sj.bjc.6602039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
275 Goyal A, Murray JM. The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology. PLoS One 2014;9:e110143. [PMID: 25313681 DOI: 10.1371/journal.pone.0110143] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
276 Marrakchi R, Ouerhani S, Benammar S, Rouissi K, Bouhaha R, Bougatef K, Messai Y, Khadimallah I, Rahal K, Ammar-elgaaied AB. Detection of Cytokeratin 19 mRNA and CYFRA 21–1 (Cytokeratin 19 Fragments) in Blood of Tunisian Women with Breast Cancer. Int J Biol Markers 2008;23:238-43. [DOI: 10.1177/172460080802300407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
277 Yang WJ, Chang CJ, Yeh SH, Lin WH, Wang SH, Tsai TF, Chen DS, Chen PJ. Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways. Hepatology. 2009;49:1515-1524. [PMID: 19205031 DOI: 10.1002/hep.22833] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 5.8] [Reference Citation Analysis]
278 Yang H, Pu H, Wang S, Ni R, Li B. Inequality of female health and its relation with urbanization level in China: geographic variation perspective. Environ Sci Pollut Res Int 2019;26:16662-73. [PMID: 30989606 DOI: 10.1007/s11356-019-04555-x] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
279 White CD, Khurana H, Gnatenko DV, Li Z, Odze RD, Sacks DB, Schmidt VA. IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. BMC Gastroenterol 2010;10:125. [PMID: 20977743 DOI: 10.1186/1471-230X-10-125] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
280 Ismail M, Bagalkotkar G, Iqbal S, Adamu HA. Anticancer properties and phenolic contents of sequentially prepared extracts from different parts of selected medicinal plants indigenous to Malaysia. Molecules 2012;17:5745-56. [PMID: 22628046 DOI: 10.3390/molecules17055745] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
281 Motawi TMK, Sadik NAH, Shaker OG, Ghaleb MH. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer. Tumor Biol 2016;37:9865-74. [DOI: 10.1007/s13277-016-4884-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
282 Sukowati CH, Rosso N, Crocè LS, Tiribelli C. Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma. World J Hepatol 2010; 2(3): 114-126 [PMID: 21160982 DOI: 10.4254/wjh.v2.i3.114] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
283 Liu J, Zhao H, Liu Y, Wang X. Effect of selenium-enriched malt on hepatocarcinogenesis, paraneoplastic syndrome and the hormones regulating blood glucose in rats treated by diethylnitrosamine. Life Sciences 2006;78:2315-21. [DOI: 10.1016/j.lfs.2005.09.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
284 Cuperjani F, Gashi L, Kurshumliu F, Dreshaj S, Selimi F. Relationship between Ribosomal Protein S6-pS240 Expression and other Prognostic Factors in Non-Special Type Invasive Breast Cancer. Breast Care (Basel) 2019;14:171-5. [PMID: 31316316 DOI: 10.1159/000491427] [Reference Citation Analysis]
285 Kamal M, Shaaban AM, Zhang L, Walker C, Gray S, Thakker N, Toomes C, Speirs V, Bell SM. Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma. Breast Cancer Res Treat 2010;121:555-63. [PMID: 19669408 DOI: 10.1007/s10549-009-0500-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
286 Schmidt HA, Goh K, Fock KM, Hilmi I, Dhamodaran S, Forman D, Mitchell H. Distinct cagA EPIYA Motifs are Associated with Ethnic Diversity in Malaysia and Singapore. Helicobacter 2009;14:256-63. [DOI: 10.1111/j.1523-5378.2009.00684.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
287 Hsu WH, Lee BH, Pan TM. Effects of red mold dioscorea on oral carcinogenesis in DMBA-induced hamster animal model. Food Chem Toxicol 2011;49:1292-7. [PMID: 21419818 DOI: 10.1016/j.fct.2011.03.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
288 Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol. 2005;34 Suppl 1:S1-S3. [PMID: 16461208 DOI: 10.1016/s1386-6532(05)00384-7] [Cited by in Crossref: 287] [Cited by in F6Publishing: 138] [Article Influence: 19.1] [Reference Citation Analysis]
289 Hadj JO, Braven RD, Tillier C, Schrijver HM, Verheul HM, VAN DER Vliet HJ. Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinoma. Oncol Lett 2012;3:1293-6. [PMID: 22783436 DOI: 10.3892/ol.2012.646] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
290 Lv B, Tao YZ, Zhu Y, Wu J, Zhong B, Luo FC, Liu Y, Zhang ZX. Comparison of the outcomes between thoracoscopic and laparoscopic esophagectomy via retrosternal and prevertebral lifting paths by the same surgeon. World J Surg Oncol 2017;15:166. [PMID: 28854945 DOI: 10.1186/s12957-017-1219-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
291 Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Korean J Intern Med. 2016;31:242-252. [PMID: 26874512 DOI: 10.3904/kjim.2015.112] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
292 Zhou YM, Li B, Xu DH, Yang JM. Safety and efficacy of partial hepatectomy for huge (≥10 cm) hepatocellular carcinoma: a systematic review. Med Sci Monit 2011;17:RA76-83. [PMID: 21358616 DOI: 10.12659/msm.881443] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
293 Shergill K, Sen A, Pillai HJ. Role of E-cadherin and cyclin D1 as predictive markers of aggression and clonal expansion in head and neck squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg 2018;44:182-90. [PMID: 30181985 DOI: 10.5125/jkaoms.2018.44.4.182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
294 Jenny B, Harrison JA, Baetens D, Tille JC, Burkhardt K, Mottaz H, Kiss JZ, Dietrich PY, De Tribolet N, Pizzolato GP, Pepper MS. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas. J Pathol 2006;209:34-43. [PMID: 16523449 DOI: 10.1002/path.1943] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 4.0] [Reference Citation Analysis]
295 Zhuang W, Wu XT, Zhou Y, Liu L, Liu GJ, Wu TX, Yao X, Du L, Wei ML. Interleukin10 -592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies. Dig Dis Sci 2010;55:1525-32. [PMID: 19669876 DOI: 10.1007/s10620-009-0922-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
296 Zhou R, Zhang M, Cheng N, Zhou Y. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: A case report. Oncol Lett 2016;11:273-6. [PMID: 26870202 DOI: 10.3892/ol.2015.3896] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
297 Hu HZ, Yang YB, Xu XD, Shen HW, Shu YM, Ren Z, Li XM, Shen HM, Zeng HT. Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line. Acta Pharmacol Sin. 2007;28:1819-1826. [PMID: 17959034 DOI: 10.1111/j.1745-7254.2007.00667.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
298 Huang P, Tong D, Sun J, Li Q, Zhang F. Generation and characterization of a human oral squamous carcinoma cell line SCC-9 with CRISPR/Cas9-mediated deletion of the p75 neurotrophin receptor. Arch Oral Biol 2017;82:223-32. [PMID: 28654784 DOI: 10.1016/j.archoralbio.2017.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
299 Yuan Z, Zeng X, Yang D, Wang W, Liu Z. Effects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer risk. PLoS One 2013;8:e61047. [PMID: 23593385 DOI: 10.1371/journal.pone.0061047] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
300 Zhang X, Long Q. Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients. Medicine (Baltimore) 2017;96:e6694. [PMID: 28445272 DOI: 10.1097/MD.0000000000006694] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
301 Wan Y, Zheng Z, Liu R, Zhu Z, Zhou H, Zhang X, Boumaraf S. A Multi-Scale and Multi-Level Fusion Approach for Deep Learning-Based Liver Lesion Diagnosis in Magnetic Resonance Images with Visual Explanation. Life (Basel) 2021;11:582. [PMID: 34207262 DOI: 10.3390/life11060582] [Reference Citation Analysis]
302 Verhoef C, Visser O, de Man R, de Wilt J, Ijzermans J, Janssen-heijnen M. Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns. European Journal of Cancer 2004;40:1530-8. [DOI: 10.1016/j.ejca.2004.03.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
303 Li H, Wang Z, Zhang W, Qian K, Xu W, Zhang S. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer. Cancer Lett. 2015; Oct 13. [Epub ahead of print]. [PMID: 26458995 DOI: 10.1016/j.canlet.2015.10.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
304 Khafagy M, Mostafa A, Fakhr I. Distribution of axillary lymph node metastases in different levels and groups in breast cancer, a pathological study. Journal of the Egyptian National Cancer Institute 2011;23:25-30. [DOI: 10.1016/j.jnci.2011.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
305 Liang S, Lin X, Liang Y, Song D, Zhang L, Fan X. Killing Effects of IFN R-/- Mouse NK Cells Activated by HN Protein of NDV on Mouse Hepatoma Cells and Possible Mechanism with Syk and NF-κB. Anat Rec (Hoboken) 2019;302:1718-25. [PMID: 31120191 DOI: 10.1002/ar.24177] [Reference Citation Analysis]
306 Rong M, Chen G, Dang Y. Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. BMC Cancer. 2013;13:21. [PMID: 23320393 DOI: 10.1186/1471-2407-13-21] [Cited by in Crossref: 77] [Cited by in F6Publishing: 88] [Article Influence: 9.6] [Reference Citation Analysis]
307 Stephen JK, Symal M, Chen KM, Ghanem T, Deeb R, Shah V, Havard S, Worsham MJ. Molecular characterization of late stomal recurrence following total laryngectomy. Oncol Rep 2011;25:669-76. [PMID: 21225233 DOI: 10.3892/or.2011.1136] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
308 Son SH, Choi BO, Ryu MR, Kang YN, Jang JS, Bae SH, Yoon SK, Choi IB, Kang KM, Jang HS. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication. Int J Radiat Oncol Biol Phys. 2010;78:1073-1080. [PMID: 20207492 DOI: 10.1016/j.ijrobp.2009.09.009] [Cited by in Crossref: 97] [Cited by in F6Publishing: 91] [Article Influence: 8.8] [Reference Citation Analysis]
309 Beale G, Chattopadhyay D, Gray J, Stewart S, Hudson M, Day C, Trerotoli P, Giannelli G, Manas D, Reeves H. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. BMC Cancer 2008;8:200. [PMID: 18638391 DOI: 10.1186/1471-2407-8-200] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 6.4] [Reference Citation Analysis]
310 La Vecchia C, Negri E, Pelucchi C. The rise and fall in primary liver cancer mortality in Italy. Dig Liver Dis. 2002;34:169-171. [PMID: 11990386 DOI: 10.1016/S1590-8658(02)80187-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
311 Lv L, Pan K, Li XD, She KL, Zhao JJ, Wang W, Chen JG, Chen YB, Yun JP, Xia JC. The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma. PLoS One. 2011;6:e18219. [PMID: 21483813 DOI: 10.1371/journal.pone.0018219] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 7.5] [Reference Citation Analysis]
312 Ha Y, Han S, Shim JH, Ko GY, Yoon HK, Sung KB, Lee D, Kim KM, Lim YS, Chung YH, Lee YS, Lee HC. Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular Carcinoma. J Vasc Interv Radiol 2015;26:1093-1101.e1. [PMID: 26077020 DOI: 10.1016/j.jvir.2015.04.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
313 Ulus T, Yurtseven E, Cavdar S, Erginoz E, Erdogan MS. The suitability of using death certificates as a data source for cancer mortality assessment in Turkey. Croat Med J 2012;53:480-5. [PMID: 23100210 DOI: 10.3325/cmj.2012.53.480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
314 Piscitelli P, Santoriello A, Buonaguro FM, Di Maio M, Iolascon G, Gimigliano F, Marinelli A, Distante A, Serravezza G, Sordi E, Cagossi K, Artioli F, Santangelo M, Fucito A, Gimigliano R, Brandi ML, Crespi M, Giordano A; CROM., Human Health Foundation Study Group. Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005. J Exp Clin Cancer Res 2009;28:86. [PMID: 19545369 DOI: 10.1186/1756-9966-28-86] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
315 Osuga K, Hori S, Hiraishi K, Sugiura T, Hata Y, Higashihara H, Maeda N, Tomoda K, Nakamura H. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol. 2008;31:1108-1116. [PMID: 18543028 DOI: 10.1007/s00270-008-9369-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
316 Dhungel B, Ramlogan-Steel CA, Steel JC. Synergistic and independent action of endogenous microRNAs 122a and 199a for post-transcriptional liver detargeting of gene vectors. Sci Rep 2018;8:15539. [PMID: 30341383 DOI: 10.1038/s41598-018-33801-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
317 Gordan JD, Chay W, Kelley RK, Ko AH, Choo S, Venook AP. “And What Other Medications Are You Taking?”. JCO 2011;29:e288-91. [DOI: 10.1200/jco.2010.32.8054] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
318 Smith-Warner SA, Spiegelman D, Yaun SS, Albanes D, Beeson WL, van den Brandt PA, Feskanich D, Folsom AR, Fraser GE, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Kushi LH, Miller AB, Pietinen P, Rohan TE, Speizer FE, Willett WC, Hunter DJ. Fruits, vegetables and lung cancer: a pooled analysis of cohort studies. Int J Cancer 2003;107:1001-11. [PMID: 14601062 DOI: 10.1002/ijc.11490] [Cited by in Crossref: 129] [Cited by in F6Publishing: 104] [Article Influence: 7.6] [Reference Citation Analysis]
319 Patel P, Young JG, Mautner V, Ashdown D, Bonney S, Pineda RG, Collins SI, Searle PF, Hull D, Peers E, Chester J, Wallace DM, Doherty A, Leung H, Young LS, James ND. A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]. Mol Ther 2009;17:1292-9. [PMID: 19367257 DOI: 10.1038/mt.2009.80] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 6.3] [Reference Citation Analysis]
320 Srinivas BK, Shivamadhu MC, Jayarama S. Musa acuminata lectin exerts anti-cancer effects on HeLa and EAC cells via activation of caspase and inhibitions of Akt, Erk, and Jnk pathway expression and suppresses the neoangiogenesis in in-vivo models. Int J Biol Macromol 2021;166:1173-87. [PMID: 33159939 DOI: 10.1016/j.ijbiomac.2020.10.272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
321 Abbas H, Hanif S, Tariq H, Chilimuri S. Thrombocytosis as a Rare Paraneoplastic Syndrome Occurring in Hepatocellular Carcinoma: A Case Report. Gastroenterology Res 2019;12:96-9. [PMID: 31019620 DOI: 10.14740/gr1137] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
322 Bressler B, Lo C, Amar J, Whittaker S, Chaun H, Halparin L, Enns R. Prospective evaluation of screening colonoscopy: who is being screened? Gastrointestinal Endoscopy 2004;60:921-6. [DOI: 10.1016/s0016-5107(04)02231-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
323 Kim H, Chung JW, Choi SH, Im S, Yamasaki Y, Jun S, Jae HJ, Park JH. Augmentation of Chemotherapeutic Infusion Effect by TSU-68, an Oral Targeted Antiangiogenic Agent, in a Rabbit VX2 Liver Tumor Model. Cardiovasc Intervent Radiol 2012;35:168-75. [DOI: 10.1007/s00270-010-0081-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
324 Ilamathi M, Prabu P, Ayyappa KA, Sivaramakrishnan V. Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signalling. Biomedicine & Pharmacotherapy 2016;82:72-9. [DOI: 10.1016/j.biopha.2016.04.061] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
325 Torimura T, Iwamoto H, Nakamura T, Koga H, Ueno T, Kerbel RS, Sata M. Metronomic chemotherapy: possible clinical application in advanced hepatocellular carcinoma. Transl Oncol 2013;6:511-9. [PMID: 24151531 DOI: 10.1593/tlo.13481] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
326 Desuki A, Staib F, Gockel I, Moehler M, Lang H, Biesterfeld S, Maderer A, Galle PR, Berger MR, Schimanski CC. Loss of LLGL1 Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases. Can J Gastroenterol Hepatol 2019;2019:2920493. [PMID: 31058107 DOI: 10.1155/2019/2920493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
327 Liao S, Zeng Z, Leung WK, Zhou S, Chen B, Sung JJY, Hu P. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism, Helicobacter pylori infection and non-cardia gastric carcinoma in Chinese. Aliment Pharmacol Ther 2006;23:289-94. [DOI: 10.1111/j.1365-2036.2006.02739.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
328 Amal H, Ding L, Liu BB, Tisch U, Xu ZQ, Shi DY, Zhao Y, Chen J, Sun RX, Liu H, Ye SL, Tang ZY, Haick H. The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs). Int J Nanomedicine 2012;7:4135-46. [PMID: 22888249 DOI: 10.2147/IJN.S32680] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
329 Inoue K, Nakane Y, Kogire M, Fujitani K, Kimura Y, Imamura H, Tamura S, Okano S, Kwon AH, Kurokawa Y, Shimokawa T, Takiuchi H, Tsujinaka T, Furukawa H. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer. Eur J Surg Oncol 2012;38:143-9. [PMID: 22154885 DOI: 10.1016/j.ejso.2011.11.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
330 Xue X, Zhang Y, Zhi Q, Tu M, Xu Y, Sun J, Wei J, Lu Z, Miao Y, Gao W. MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Cell Commun Signal 2014;12:62. [PMID: 25269476 DOI: 10.1186/s12964-014-0062-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
331 Loriot Y, Soria J, Le Chevalier T. Expanding role of chemotherapy in lung cancer. Annals of Oncology 2006;17:x101-7. [DOI: 10.1093/annonc/mdl246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
332 Zhou W, Zhang L, Wang K, Chen S, Wang G, Liu Z, Liang C. Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images. J Magn Reson Imaging. 2017;45:1476-1484. [PMID: 27626270 DOI: 10.1002/jmri.25454] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 12.6] [Reference Citation Analysis]
333 Bu T, Liu L, Sun Y, Zhao L, Peng Y, Zhou S, Li L, Chen S, Gao Y. XRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: a meta-analysis of 10846 cases and 11723 controls. PLoS One 2014;9:e86086. [PMID: 24489692 DOI: 10.1371/journal.pone.0086086] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
334 Iwanski GB, Block A, Keller G, Muench J, Claus S, Fiedler W, Bokemeyer C. Esophageal squamous cell carcinoma presenting with extensive skin lesions: a case report. J Med Case Rep 2008;2:115. [PMID: 18426583 DOI: 10.1186/1752-1947-2-115] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
335 Yau T, Yao TJ, Chan P, Epstein RJ, Ng KK, Chok SH, Cheung TT, Fan ST, Poon RT. The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization. Cancer. 2009;115:5507-5515. [PMID: 19701904 DOI: 10.1002/cncr.24636] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
336 Winter JM, Maitra A, Yeo CJ. Genetics and pathology of pancreatic cancer. HPB (Oxford). 2006;8:324-336. [PMID: 18333084 DOI: 10.1080/13651820600804203] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
337 Yu Y, Shen H, Yu H, Zhong F, Zhang Y, Zhang C, Zhao J, Li H, Chen J, Liu Y, Yang P. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis. Mol BioSyst 2011;7:1908. [DOI: 10.1039/c0mb00265h] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
338 Jain N, Singh V, Hedau S, Kumar S, Daga MK, Dewan R, Murthy NS, Husain SA, Das BC. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 2005;128:3999-4007. [PMID: 16354872 DOI: 10.1378/chest.128.6.3999] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
339 Kitisin K, Ganesan N, Tang Y, Jogunoori W, Volpe EA, Kim SS, Katuri V, Kallakury B, Pishvaian M, Albanese C. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. Oncogene. 2007;26:7103-7110. [PMID: 17546056 DOI: 10.1038/sj.onc.1210513] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 6.0] [Reference Citation Analysis]
340 Ding X, Feng L, Ma L. Diagnosis of recurrent uterine cervical cancer: PET versus PET/CT: a systematic review and meta-analysis. Arch Gynecol Obstet 2014;290:741-7. [DOI: 10.1007/s00404-014-3263-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
341 Yang T, He X, Chen A, Tan K, Du X. LncRNA HOTAIR contributes to the malignancy of hepatocellular carcinoma by enhancing epithelial-mesenchymal transition via sponging miR-23b-3p from ZEB1. Gene. 2018;670:114-122. [PMID: 29778425 DOI: 10.1016/j.gene.2018.05.061] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 13.0] [Reference Citation Analysis]
342 Carvalho R, Milne AN, Polak M, Offerhaus GJ, Weterman MA. A novel region of amplification at 11p12-13 in gastric cancer, revealed by representational difference analysis, is associated with overexpression of CD44v6, especially in early-onset gastric carcinomas. Genes Chromosomes Cancer. 2006;45:967-975. [PMID: 16868940 DOI: 10.1002/gcc.20360] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
343 Moon A, Lim SJ, Jo YH, Lee S, Kim JY, Lee J, Park JH. Downregulation of GLTSCR2 expression is correlated with breast cancer progression. Pathol Res Pract 2013;209:700-4. [PMID: 24054033 DOI: 10.1016/j.prp.2013.07.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
344 Wu MY, Kuo CS, Lin CY, Lu CL, Syu Huang RF. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study. Br J Nutr 2009;102:715-21. [PMID: 19331700 DOI: 10.1017/S0007114509243054] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
345 Kontos CK, Papadopoulos IN, Fragoulis EG, Scorilas A. Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma. Br J Cancer 2010;102:1384-90. [PMID: 20424616 DOI: 10.1038/sj.bjc.6605654] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
346 Chen MH, Chang PM, Chen PM, Tzeng CH, Chu PY, Chang SY, Yang MH. Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer. J Cancer Res Clin Oncol 2009;135:1783-90. [PMID: 19551407 DOI: 10.1007/s00432-009-0625-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
347 Hucke F, Sieghart W, Schöniger-Hekele M, Peck-Radosavljevic M, Müller C. Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program? Wien Klin Wochenschr. 2011;123:542-551. [PMID: 21800047 DOI: 10.1007/s00508-011-0033-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
348 Wei R, Zhang M, Rao H, Pu H, Zhang H, Wang H. Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma. Med Oncol 2012;29:2737-43. [DOI: 10.1007/s12032-011-0126-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
349 Lin CY, Liao CW, Chu LY, Yen KY, Jeng LB, Hsu CN, Lin CL, Kao CH. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation. Clin Nucl Med. 2017;42:e183-e187. [PMID: 28114226 DOI: 10.1097/rlu.0000000000001545] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
350 Katsuta E, Tanaka S, Mogushi K, Matsumura S, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanaka H, Tanabe M, Arii S. Age-related clinicopathologic and molecular features of patients receiving curative hepatectomy for hepatocellular carcinoma. The American Journal of Surgery 2014;208:450-6. [DOI: 10.1016/j.amjsurg.2014.01.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
351 Zhou L, Rui JA, Zhou WX, Wang SB, Chen SG, Qu Q. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio. Pathol Res Pract 2017;213:824-30. [PMID: 28554743 DOI: 10.1016/j.prp.2017.03.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
352 Park SS, Kim MA, Eom YW, Choi KS. Bcl-xL blocks high dose doxorubicin-induced apoptosis but not low dose doxorubicin-induced cell death through mitotic catastrophe. Biochem Biophys Res Commun. 2007;363:1044-1049. [PMID: 17923112 DOI: 10.1016/j.bbrc.2007.09.037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
353 Weinberg L, Abu-Ssaydeh D, Macgregor C, Wang J, Wong C, Spanger M, Muralidharan V. Transjugular biopsy case report of inferior vena cava hepatocellular carcinoma with intracardiac extension. Int J Surg Case Rep 2017;39:324-7. [PMID: 28898796 DOI: 10.1016/j.ijscr.2017.08.057] [Reference Citation Analysis]
354 Marrero JA, Pelletier S. Hepatocellular Carcinoma. Clinics in Liver Disease 2006;10:339-51. [DOI: 10.1016/j.cld.2006.05.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
355 Sasahira T, Kirita T, Kurihara M, Yamamoto K, Bhawal UK, Bosserhoff AK, Kuniyasu H. MIA-dependent angiogenesis and lymphangiogenesis are closely associated with progression, nodal metastasis and poor prognosis in tongue squamous cell carcinoma. European Journal of Cancer 2010;46:2285-94. [DOI: 10.1016/j.ejca.2010.04.027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
356 Zhou Y, Ling XL, Li SW, Li XQ, Yan B. Establishment of a human hepatoma multidrug resistant cell line in vitroWorld J Gastroenterol 2010; 16(18): 2291-2297 [PMID: 20458768 DOI: 10.3748/wjg.v16.i18.2291] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
357 Paradkar S, Pande SS. Intelligent detection of microcalcification from digitized mammograms. Sadhana 2011;36:125-39. [DOI: 10.1007/s12046-011-0003-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
358 Sepehr A, Kamangar F, Abnet CC, Fahimi S, Pourshams A, Poustchi H, Zeinali S, Sotoudeh M, Islami F, Nasrollahzadeh D. Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison. Cancer Lett. 2004;213:195-202. [PMID: 15327835 DOI: 10.1016/j.canlet.2004.05.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
359 Sun JH, Wang LG, Bao HW, Lou JL, Cai LX, Wu C, Chen LM, Zheng SS. Usefulness of C-arm angiographic computed tomography for detecting iodized oil retention during transcatheter arterial chemoembolization of hepatocellular carcinoma. J Int Med Res 2010;38:1259-65. [PMID: 20925998 DOI: 10.1177/147323001003800407] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
360 Yan F, Wang XM, Pan C, Ma QM. Down-regulation of extracellular signal-regulated kinase 1/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells. World J Gastroenterol 2009; 15(12): 1443-1451 [PMID: 19322916 DOI: 10.3748/wjg.15.1443] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
361 Takahashi M, Kitahashi T, Ishigamori R, Mutoh M, Komiya M, Sato H, Kamanaka Y, Naka M, Maruyama T, Sugimura T, Wakabayashi K. Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor. Carcinogenesis 2008;29:1608-13. [PMID: 18567618 DOI: 10.1093/carcin/bgn152] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
362 Oquiñena S, Guillen-Grima F, Iñarrairaegui M, Zozaya JM, Sangro B. Spontaneous regression of hepatocellular carcinoma: a systematic review. Eur J Gastroenterol Hepatol 2009;21:254-7. [PMID: 19279469 DOI: 10.1097/MEG.0b013e328324b6a2] [Cited by in Crossref: 49] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
363 Seiwert TY, Cohen EE. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 2005;92:1341-8. [PMID: 15846296 DOI: 10.1038/sj.bjc.6602510] [Cited by in Crossref: 176] [Cited by in F6Publishing: 162] [Article Influence: 11.0] [Reference Citation Analysis]
364 Dueñas-gonzález A, Cetina-perez L, Lopez-graniel C, Gonzalez-enciso A, Gómez-gonzalez E, Rivera-rubi L, Montalvo-esquivel G, Muñoz-gonzalez D, Robles-flores J, Vazquez-govea E, de La Garza J, Mohar A. Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: A randomized Phase II study. International Journal of Radiation Oncology*Biology*Physics 2005;61:817-23. [DOI: 10.1016/j.ijrobp.2004.07.676] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
365 Song MJ, Bae SH, Chun HJ, Choi JY, Yoon SK, Park JY, Han KH, Kim YS, Yim HJ, Um SH, Chung WJ, Hwang JS, Cho S, Eun JR. A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 2015;75:739-46. [DOI: 10.1007/s00280-015-2692-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
366 Voigt MD. Alcohol in hepatocellular cancer. Clin Liver Dis. 2005;9:151-169. [PMID: 15763234 DOI: 10.1016/j.cld.2004.10.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
367 Kroupis C, Thomopoulou G, Papathomas TG, Vourlidis N, Lazaris AC. Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece. Epidemiol Infect 2007;135:943-50. [PMID: 17553178 DOI: 10.1017/S095026880700876X] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
368 Samuelian JM, Fisher BJ, Daugherty LC, Babaria UA. Oropharyngeal squamous cell carcinoma metastatic to lower-extremity soft tissues: a case report and literature review. Ear Nose Throat J 2013;92:E38. [PMID: 23780603 DOI: 10.1177/014556131309200621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
369 Masuzaki R, Yoshida H, Tateishi R, Shiina S, Omata M. Hepatocellular carcinoma in viral hepatitis: improving standard therapy. Best Pract Res Clin Gastroenterol. 2008;22:1137-1151. [PMID: 19187872 DOI: 10.1016/j.bpg.2008.11.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
370 Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C. Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol. 2005;16:489-511. [PMID: 15668262 DOI: 10.1093/annonc/mdi086] [Cited by in Crossref: 104] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
371 Xu SP, Sun GP, Shen YX, Wei W, Peng WR, Wang H. Antiproliferation and apoptosis induction of paeonol in HepG2 cells. World J Gastroenterol 2007; 13(2): 250-256 [PMID: 17226904 DOI: 10.3748/wjg.v13.i2.250] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
372 Al-Saleh MA, Punithakumar K, Lagravere M, Boulanger P, Jaremko JL, Wolfaardt J, Major PW, Seikaly H. Three-dimensional morphological changes of the temporomandibular joint and functional effects after mandibulotomy. J Otolaryngol Head Neck Surg 2017;46:8. [PMID: 28129794 DOI: 10.1186/s40463-017-0184-4] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
373 Lee YS, Cho YS, Lee GK, Lee S, Kim YW, Jho S, Kim HM, Hong SH, Hwang JA, Kim SY. Genomic profile analysis of diffuse-type gastric cancers. Genome Biol. 2014;15:R55. [PMID: 24690483 DOI: 10.1186/gb-2014-15-4-r55] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
374 Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. J Gastroenterol Hepatol. 2009;24:806-814. [PMID: 19207681 DOI: 10.1111/j.1440-1746.2008.05728.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 8.2] [Reference Citation Analysis]
375 Wu T. Cyclooxygenase-2 in hepatocellular carcinoma. Cancer Treat Rev. 2006;32:28-44. [PMID: 16337744 DOI: 10.1016/j.ctrv.2005.10.004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 5.5] [Reference Citation Analysis]
376 Xie Y, Sheng W, Xiang J, Ye Z, Yang J. Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis. Cancer Invest 2010;28:598-607. [PMID: 20210523 DOI: 10.3109/07357900903287030] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
377 Wang Y, Kang S, Doerksen JD, Glaser AK, Liu JT. Surgical Guidance via Multiplexed Molecular Imaging of Fresh Tissues Labeled with SERS-Coded Nanoparticles. IEEE J Sel Top Quantum Electron 2016;22:6802911. [PMID: 27524875 DOI: 10.1109/JSTQE.2015.2507358] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
378 Hou YB, Chen MH, Yan K, Wu JY, Yang W. Adjuvant percutaneous radiofrequency ablation of feeding artery of hepatocellular carcinoma before treatment. World J Gastroenterol 2009; 15(21): 2638-2643 [PMID: 19496195 DOI: 10.3748/wjg.15.2638] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
379 Banerjee S, Das T, Chakraborty S, Venkatesh M. Emergence and present status of Lu-177 in targeted radiotherapy: the Indian scenario. ract 2012;100:115-26. [DOI: 10.1524/ract.2011.1843] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
380 Renzulli M, Peta G, Vasuri F, Marasco G, Caretti D, Bartalena L, Spinelli D, Giampalma E, D'Errico A, Golfieri R. Standardization of conventional chemoembolization for hepatocellular carcinoma. Ann Hepatol 2021;22:100278. [PMID: 33129978 DOI: 10.1016/j.aohep.2020.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
381 Volk M, Marrero JA. Liver Transplantation for Hepatocellular Carcinoma: Who Benefits and Who Is Harmed? Gastroenterology 2008;134:1612-4. [DOI: 10.1053/j.gastro.2008.03.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
382 Koidl C, Bozic M, Hadzisejdic I, Grahovac M, Grahovac B, Kranewitter W, Marth E, Kessler HH. Comparison of molecular assays for detection and typing of human papillomavirus. Am J Obstet Gynecol 2008;199:144.e1-6. [PMID: 18439557 DOI: 10.1016/j.ajog.2008.03.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
383 Kuo YH, Lu SN, Chen CL, Cheng YF, Lin CY, Hung CH, Chen CH, Changchien CS, Hsu HC, Hu TH. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis. Eur J Cancer. 2010;46:744-751. [PMID: 20060710 DOI: 10.1016/j.ejca.2009.12.018] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 6.1] [Reference Citation Analysis]
384 Aoyagi Y, Tamura Y, Suda T. History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction: Editorials. Journal of Gastroenterology and Hepatology 2011;26:615-6. [DOI: 10.1111/j.1440-1746.2011.06671.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
385 Chen F, Hu P, Liang N, Xie J, Yu S, Tian T, Zhang J, Deng G, Zhang J. Concurrent chemoradiotherapy with weekly nedaplatin versus radiotherapy alone in elderly patients with non-small-cell lung cancer. Clin Transl Oncol 2018;20:294-301. [PMID: 28741074 DOI: 10.1007/s12094-017-1716-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
386 Nabukenya J, Hadlock TA, Arubaku W. Head and Neck Squamous Cell Carcinoma in Western Uganda: Disease of Uncertainty and Poor Prognosis. OTO Open 2018;2:2473974X18761868. [PMID: 30480207 DOI: 10.1177/2473974X18761868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
387 Qi X, Schepers E, Avella D, Kimchi ET, Kaifi JT, Staveley-O'Carroll KF, Li G. An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis. J Vis Exp 2019. [PMID: 31566616 DOI: 10.3791/59368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
388 Cao M, Hou D, Liang H, Gong F, Wang Y, Yan X, Jiang X, Wang C, Zhang J, Zen K, Zhang CY, Chen X. miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1. Eur J Cancer 2014;50:1013-24. [PMID: 24456795 DOI: 10.1016/j.ejca.2013.12.024] [Cited by in Crossref: 70] [Cited by in F6Publishing: 77] [Article Influence: 10.0] [Reference Citation Analysis]
389 Stagos D, Amoutzias GD, Matakos A, Spyrou A, Tsatsakis AM, Kouretas D. Chemoprevention of liver cancer by plant polyphenols. Food and Chemical Toxicology 2012;50:2155-70. [DOI: 10.1016/j.fct.2012.04.002] [Cited by in Crossref: 100] [Cited by in F6Publishing: 85] [Article Influence: 11.1] [Reference Citation Analysis]
390 张昌明, 张建龙, 张琼, 张铸, 张海平, 孙清超, 丁旭, 刘钰莉, 伊力亚尔·夏合丁. 新疆汉族、维吾尔族及哈萨克族食管癌血清蛋白质指纹图谱. 世界华人消化杂志 2010; 18(17): 1773-1779 [DOI: 10.11569/wcjd.v18.i17.1773] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
391 Xu XL, Xing BC, Han HB, Zhao W, Hu MH, Xu ZL, Li JY, Xie Y, Gu J, Wang Y. The properties of tumor-initiating cells from a hepatocellular carcinoma patient’s primary and recurrent tumor. Carcinogenesis. 2010;31:167-174. [PMID: 19897602 DOI: 10.1093/carcin/bgp232] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 5.3] [Reference Citation Analysis]
392 Alves-Bezerra M, Furey N, Johnson CG, Bissig KD. Using CRISPR/Cas9 to model human liver disease. JHEP Rep 2019;1:392-402. [PMID: 32039390 DOI: 10.1016/j.jhepr.2019.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
393 Nagaoka S, Itano S, Ishibashi M, Torimura T, Baba K, Akiyoshi J, Kurogi J, Matsugaki S, Inoue K, Tajiri N, Takada A, Ando E, Kuromatsu R, Kaida H, Kurogi M, Koga H, Kumashiro R, Hayabuchi N, Kojiro M, Sata M. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings. Liver Int 2006;26:781-8. [DOI: 10.1111/j.1478-3231.2006.01296.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
394 Muthu K, Panneerselvam M, Jayaraman M, Topno NS, Das AA, Ramadas K. Structural insights into interacting mechanism of ID1 protein with an antagonist ID1/3-PA7 and agonist ETS-1 in treatment of ovarian cancer: molecular docking and dynamics studies. J Mol Model 2012;18:4865-84. [DOI: 10.1007/s00894-012-1489-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
395 Patel N, Desai J, Kumar P, Thakkar HP. Development and In Vitro Characterization of Capecitabine-Loaded Alginate–Pectinate–Chitosan Beads for Colon Targeting. Journal of Macromolecular Science, Part B 2015;55:33-54. [DOI: 10.1080/00222348.2015.1110551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
396 Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F; EUROCARE Working Group. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol 2007;102:1661-70; quiz 1660, 1671. [PMID: 17555459 DOI: 10.1111/j.1572-0241.2007.01337.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 7.1] [Reference Citation Analysis]
397 Ardiles V, Sánchez Clariá R, Mazza OM, Ciardullo MA, Pekolj J, De Santibañes E. [Prognostic factors after resection of hepatocellular carcinoma in the non-cirrhotic liver: presentation of 51 cases]. Cir Esp 2010;87:148-54. [PMID: 20096405 DOI: 10.1016/j.ciresp.2009.11.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
398 Forns X, Sánchez Tapias JM, Parés A, Llovet JM, Bruix J, Rodés J. Expected developments in hepatology. Best Practice & Research Clinical Gastroenterology 2002;16:957-70. [DOI: 10.1053/bega.2002.0341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
399 Nicholls R, Perry L, Gallagher R, Duffield C, Sibbritt D, Xu X. The personal cancer screening behaviours of nurses and midwives. J Adv Nurs 2017;73:1403-20. [DOI: 10.1111/jan.13221] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
400 Tipirisetti NR, Lakshmi RK, Govatati S, Govatati S, Vuree S, Singh L, Raghunadha Rao D, Bhanoori M, Vishnupriya S. Mitochondrial genome variations in advanced stage breast cancer: A case–control study. Mitochondrion 2013;13:372-8. [DOI: 10.1016/j.mito.2013.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
401 Pan K, Wang H, Chen M, Zhang H, Weng D, Zhou J, Huang W, Li J, Song H, Xia J. Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma. J Cancer Res Clin Oncol 2008;134:1247-53. [DOI: 10.1007/s00432-008-0395-1] [Cited by in Crossref: 102] [Cited by in F6Publishing: 108] [Article Influence: 7.8] [Reference Citation Analysis]
402 Mutlu H, Akca Z, Teke HU, Ugur H. Evaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline. Eurasian J Med 2011;43:173-6. [PMID: 25610187 DOI: 10.5152/eajm.2011.36] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
403 Lombardi G, Zustovich F, Farinati F, Cillo U, Vitale A, Zanus G, Donach M, Farina M, Zovato S, Pastorelli D. Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma: Results of a phase 2 study. Cancer 2011;117:125-33. [DOI: 10.1002/cncr.25578] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
404 Ren X, Cheng Y, Wu S, Zeng X, Shi X, Ling Q, Li Z, Liang Z, Wang B. Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status. Diagn Pathol 2020;15:30. [PMID: 32238190 DOI: 10.1186/s13000-020-00936-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
405 Kierans AS, Kang SK, Rosenkrantz AB. The Diagnostic Performance of Dynamic Contrast-enhanced MR Imaging for Detection of Small Hepatocellular Carcinoma Measuring Up to 2 cm: A Meta-Analysis. Radiology 2016;278:82-94. [PMID: 26098460 DOI: 10.1148/radiol.2015150177] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 9.5] [Reference Citation Analysis]
406 Soundararajan A, Bao A, Phillips WT, Perez R 3rd, Goins BA. [(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model. Nucl Med Biol 2009;36:515-24. [PMID: 19520292 DOI: 10.1016/j.nucmedbio.2009.02.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
407 Lee VH, Chow BK, Lo K, Chow LS, Man C, Tsao S, Lee LT. Regulation of RASSF1A in nasopharyngeal cells and its response to UV irradiation. Gene 2009;443:55-63. [DOI: 10.1016/j.gene.2009.05.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
408 Lee M, Lee Y, Hwang KH, Choe W, Park CY. Usefulness of F-18 FDG PET/CT in Assessment of Recurrence of Cervical Cancer After Treatment. Nucl Med Mol Imaging 2011;45:111-6. [PMID: 24899989 DOI: 10.1007/s13139-010-0059-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
409 Tahara T, Arisawa T, Shibata T, Hirata I, Nakano H. Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. J Gastroenterol Hepatol 2007;22:1678-82. [PMID: 17608636 DOI: 10.1111/j.1440-1746.2007.04848.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
410 Lee YJ, Lee CG, Cho BC, Kim GE, Choi HJ, Choi EC, Sohn JH, Kim JH. Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer. Head Neck 2010;32:235-43. [PMID: 19572288 DOI: 10.1002/hed.21177] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
411 Shibata T, Shibata T, Maetani Y, Isoda H, Hiraoka M. Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology. 2006;238:346-353. [PMID: 16373776 DOI: 10.1148/radiol.2381041848] [Cited by in Crossref: 105] [Cited by in F6Publishing: 77] [Article Influence: 7.0] [Reference Citation Analysis]
412 Gong Y, Yang H, Tian X. Elucidating the mechanism of miRNA-214 in the regulation of gingival carcinoma. Exp Ther Med 2017;13:2544-50. [PMID: 28565877 DOI: 10.3892/etm.2017.4264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
413 Jiang J, Huang L, Liang X, Zhou X, Huang R, Chu Z, Zhan Q. Gefitinib versus docetaxel in previously treated advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials. Acta Oncol 2011;50:582-8. [PMID: 21190510 DOI: 10.3109/0284186X.2010.546368] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
414 Wang K. Role of Laparoscopic Lymphadenectomy in the Management of Cervical Cancer. Taiwanese Journal of Obstetrics and Gynecology 2005;44:301-13. [DOI: 10.1016/s1028-4559(09)60162-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
415 Hruban RH, Klein AP, Eshleman JR, Axilbund JE, Goggins M. Familial pancreatic cancer: from genes to improved patient care. Expert Rev Gastroenterol Hepatol 2007;1:81-8. [PMID: 19072437 DOI: 10.1586/17474124.1.1.81] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
416 Shyu YC, Lee TL, Lu MJ, Chen JR, Chien RN, Chen HY, Lin JF, Tsou AP, Chen YH, Hsieh CW, Huang TS. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma. J Transl Med 2016;14:200. [PMID: 27370270 DOI: 10.1186/s12967-016-0956-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
417 Al-Tahhan MA, Etewa RL, El Behery MM. Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women. Mol Cell Biochem 2011;353:159-65. [PMID: 21424904 DOI: 10.1007/s11010-011-0782-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
418 Mishra A, Bharti AC, Saluja D, Das BC. Transactivation and expression patterns of Jun and Fos/AP-1 super-family proteins in human oral cancer. Int J Cancer 2010;126:819-29. [PMID: 19653276 DOI: 10.1002/ijc.24807] [Cited by in Crossref: 14] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
419 Xu Z, Zhang M, Lv X, Xiang D, Zhang X, Chen L. The inhibitory effect of celecoxib on mouse hepatoma H22 cell line on the arachidonic acid metabolic pathway. Biochem Cell Biol. 2010;88:603-609. [PMID: 20651831 DOI: 10.1139/O09-184] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
420 Bharadwaj M, Roy G, Dutta K, Misbah M, Husain M, Hussain S. Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now. Cancer Metastasis Rev. 2013;32:229-268. [PMID: 23114844 DOI: 10.1007/s10555-012-9412-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
421 Anner P, Mayerhöfer M, Wadsak W, Geleff S, Dudczak R, Haug A, Hacker M, Karanikas G. [18F]FDG-PET/CT and MRI for initial pelvic lymph node staging in patients with cervical carcinoma: The potential usefulness of [18F]FDG-PET/MRI. Oncol Lett 2018;15:3951-6. [PMID: 29467905 DOI: 10.3892/ol.2018.7775] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
422 Yamashita H, Okuma K, Nomoto A, Yamashita M, Igaki H, Nakagawa K. Extended cancer-free survival after palliative chemoradiation for metastatic esophageal cancer. World J Gastrointest Oncol 2014; 6(2): 52-54 [PMID: 24567796 DOI: 10.4251/wjgo.v6.i2.52] [Reference Citation Analysis]
423 Raimondi S, Mabrouk JB, Shatenstein B, Maisonneuve P, Ghadirian P. Diet and prostate cancer risk with specific focus on dairy products and dietary calcium: a case-control study. Prostate 2010;70:1054-65. [PMID: 20232354 DOI: 10.1002/pros.21139] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
424 Griewank KG, Murali R. Pathology and genetics of uveal melanoma. Pathology 2013;45:18-27. [DOI: 10.1097/pat.0b013e32835c6505] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
425 Alsina AE, Makris A, Nenos V, Sucre E, Arrobas J, Franco E, Kemmer N. Can sorafenib increase survival for recurrent hepatocellular carcinoma after liver transplantation? Am Surg. 2014;80:680-684. [PMID: 24987900 DOI: 10.1177/000313481408000723] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
426 Chen L, Zhang Y, Kong X, Lan E, Huang Z, Peng S, Kaufman DL, Tian J. Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid. J Med Chem 2008;51:4834-8. [PMID: 18598019 DOI: 10.1021/jm800167u] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 6.0] [Reference Citation Analysis]
427 Zhou Y, Zhang Z, Zhang Z, Wu J, Ren D, Yan X, Wang Q, Wang Y, Wang H, Zhang J, Zhu X, Yang Y, Luo C, Guo X, Tang C, Qiao L. A rising trend of gastric cardia cancer in Gansu Province of China. Cancer Lett. 2008;269:18-25. [PMID: 18501504 DOI: 10.1016/j.canlet.2008.04.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
428 Imai K, Beppu T, Chikamoto A, Doi K, Okabe H, Hayashi H, Nitta H, Ishiko T, Takamori H, Baba H. Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or less. Hepatol Res. 2013;43:853-864. [PMID: 23281579 DOI: 10.1111/hepr.12035] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
429 Rossi A, Maione P, Gridelli C. Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients. Expert Opin Drug Saf 2005;4:1051-67. [PMID: 16255664 DOI: 10.1517/14740338.4.6.1051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
430 Pedroza-Gonzalez A, Zhou G, Singh SP, Boor PP, Pan Q, Grunhagen D, de Jonge J, Tran TK, Verhoef C, IJzermans JN. GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells ex vivo. Oncoimmunology. 2015;4:e1051297. [PMID: 26587321 DOI: 10.1080/2162402x.2015.1051297] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
431 Zhang J, Luo X, Huang Q, Huang Y. Clinicopathological and prognostic features of nasopharyngeal carcinoma in children and adolescents: A retrospective study of 196 cases in South China. Int J Cancer 2021;148:1087-96. [PMID: 32930415 DOI: 10.1002/ijc.33293] [Reference Citation Analysis]
432 Zhang L, Ge N, Chen Y, Xie X, Yin X, Gan Y, Zhang B, Zhang J, Chen R, Wang Y, Ye S, Ren Z. Long-term outcomes and prognostic analysis of radiofrequency ablation for small hepatocellular carcinoma: 10-year follow-up in Chinese patients. Med Oncol 2015;32. [DOI: 10.1007/s12032-015-0532-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
433 Tarney CM, Han J. Postcoital bleeding: a review on etiology, diagnosis, and management. Obstet Gynecol Int 2014;2014:192087. [PMID: 25045355 DOI: 10.1155/2014/192087] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
434 Chadha S, Kumar A, Srivastava SA, Behl T, Ranjan R. Inulin as a Delivery Vehicle for Targeting Colon-Specific Cancer. Curr Drug Deliv 2020;17:651-74. [PMID: 32459607 DOI: 10.2174/1567201817666200527133719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
435 Kwon MS, Shin S, Yim S, Lee KY, Kang H, Kim T, Chung Y. CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung. Lung Cancer 2007;57:46-53. [DOI: 10.1016/j.lungcan.2007.01.032] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
436 Ippolito D, Colombo M, Trattenero C, Bonaffini PA, Talei Franzesi C, Fior D, Sironi S. Diagnostic Value of Semiquantitative Analysis of Dynamic Susceptibility Contrast Magnetic Resonance Imaging with GD-EOB-DTPA in Focal Liver Lesions Characterization: A Feasibility Study. Gastroenterol Res Pract. 2015;2015:630273. [PMID: 26064093 DOI: 10.1155/2015/630273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
437 Khatoon J, Rai RP, Prasad KN. Role of Helicobacter pylori in gastric cancer: Updates. World J Gastrointest Oncol 2016; 8(2): 147-158 [PMID: 26909129 DOI: 10.4251/wjgo.v8.i2.147] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
438 Sanaei M, Kavoosi F, Valiani A, Ghobadifar MA. Effect of Genistein on Apoptosis and Proliferation of Hepatocellular Carcinoma Hepa1-6 Cell Line. Int J Prev Med 2018;9:12. [PMID: 29541427 DOI: 10.4103/ijpvm.IJPVM_249_16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
439 Mizukoshi E, Nakamoto Y, Arai K, Yamashita T, Sakai A, Sakai Y, Kagaya T, Yamashita T, Honda M, Kaneko S. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma. Hepatology. 2011;53:1206-1216. [PMID: 21480325 DOI: 10.1002/hep.24149] [Cited by in Crossref: 110] [Cited by in F6Publishing: 106] [Article Influence: 11.0] [Reference Citation Analysis]
440 Fathy M, Nikaido T. In vivo modulation of iNOS pathway in hepatocellular carcinoma by Nigella sativa. Environ Health Prev Med 2013;18:377-85. [PMID: 23609474 DOI: 10.1007/s12199-013-0336-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
441 Toyama T, Nitta N, Ohta S, Tanaka T, Nagatani Y, Takahashi M, Murata K, Shiomi H, Naka S, Kurumi Y, Tani T, Tabata Y. Clinical trial of cisplatin-conjugated gelatin microspheres for patients with hepatocellular carcinoma. Jpn J Radiol 2012;30:62-8. [PMID: 22194039 DOI: 10.1007/s11604-011-0010-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
442 Altomonte J, Wu L, Chen L, Meseck M, Ebert O, García-Sastre A, Fallon J, Woo SL. Exponential enhancement of oncolytic vesicular stomatitis virus potency by vector-mediated suppression of inflammatory responses in vivo. Mol Ther 2008;16:146-53. [PMID: 18071337 DOI: 10.1038/sj.mt.6300343] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
443 Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C, Wang C, Ren Z, Zhao Y, Wu S. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer. 2012;130:1620-1628. [PMID: 21557218 DOI: 10.1002/ijc.26177] [Cited by in Crossref: 205] [Cited by in F6Publishing: 198] [Article Influence: 20.5] [Reference Citation Analysis]
444 Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, Durnez A, Demetris AJ, Thorgeirsson SS. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004;40:667-676. [PMID: 15349906 DOI: 10.1002/hep.20375] [Cited by in Crossref: 599] [Cited by in F6Publishing: 547] [Article Influence: 35.2] [Reference Citation Analysis]
445 Sand M, Sand D, Thrandorf C, Paech V, Altmeyer P, Bechara FG. Cutaneous lesions of the nose. Head Face Med 2010;6:7. [PMID: 20525327 DOI: 10.1186/1746-160X-6-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
446 Dawson NA. Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease. Expert Opinion on Pharmacotherapy 2005;4:705-16. [DOI: 10.1517/14656566.4.5.705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
447 Mokarram P, Zamani M, Kavousipour S, Naghibalhossaini F, Irajie C, Moradi Sarabi M, Hosseini SV. Different patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer. Mol Biol Rep. 2013;40:3851-3857. [PMID: 23271133 DOI: 10.1007/s11033-012-2465-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
448 Gridelli C, Maione P, Rossi A, De Marinis F. The role of bevacizumab in the treatment of non-small cell lung cancer: current indications and future developments. Oncologist 2007;12:1183-93. [PMID: 17962612 DOI: 10.1634/theoncologist.12-10-1183] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
449 Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell. 2004;5:215-219. [PMID: 15050913 DOI: 10.1016/s1535-6108(04)00058-3] [Cited by in Crossref: 414] [Cited by in F6Publishing: 190] [Article Influence: 24.4] [Reference Citation Analysis]
450 Sohn S, Chung CK, Sohn MJ, Kim SH, Kim J, Park E. Radiosurgery Compared with External Radiation Therapy as a Primary Treatment in Spine Metastasis from Hepatocellular Carcinoma : A Multicenter, Matched-Pair Study. J Korean Neurosurg Soc 2016;59:37-43. [PMID: 26885284 DOI: 10.3340/jkns.2016.59.1.37] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
451 Liu Z, Su YJ, Gu PQ, Ji ZY, Wang XG, Gao LJ. The role of the globular heads of C1q receptor (gC1qR) gene in regulating apoptosis of human cervical squamous cell carcinoma. Cell Physiol Biochem 2012;30:1181-90. [PMID: 23052251 DOI: 10.1159/000343308] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
452 Ma X, Li Q, Wang J, Shao J, Zhu Y, Ding W, Zhang H, Wang H, Shen J. Comparison of elastography based on transvaginal ultrasound and MRI in assessing parametrial invasion of cervical cancer. CH 2017;66:27-35. [DOI: 10.3233/ch-16235] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
453 Cho HJ, Kim SS, Wang HJ, Kim BW, Cho H, Jung J, Cho SS, Kim JK, Lee JH, Kim YB. Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up. DNA Cell Biol. 2016;35:71-80. [PMID: 26624274 DOI: 10.1089/dna.2015.3026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
454 Sakaeda T, Yamamori M, Kuwahara A, Nishiguchi K. Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy. Adv Drug Deliv Rev 2009;61:388-401. [PMID: 19135108 DOI: 10.1016/j.addr.2008.10.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
455 Khan R, Kazmi I, Afzal M, Al Abbasi FA, Mushtaq G, Ahmad A, Kumar V, Anwar F. Fixed dose combination therapy loperamide and niacin ameliorates diethylnitrosamine-induced liver carcinogenesis in albino Wistar rats. RSC Adv 2015;5:67996-8002. [DOI: 10.1039/c5ra11201j] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
456 Riddell AM, Hillier J, Brown G, King DM, Wotherspoon AC, Thompson JN, Cunningham D, Allum WH. Potential of Surface-Coil MRI for Staging of Esophageal Cancer. American Journal of Roentgenology 2006;187:1280-7. [DOI: 10.2214/ajr.05.0559] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
457 Bamal R, Chintamani, Tandon M, Mittal MK, Saxena S. Evaluation and Validation of Neo-Adjuvant Response Index (NRI) and It's Correlation with Various Predictive Biomarkers and RECIST in Locally Advanced Breast Cancer. Indian J Surg Oncol 2014;5:171-7. [PMID: 25419059 DOI: 10.1007/s13193-014-0336-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
458 Neri B, Pantaleo P, Giommoni E, Grifoni R, Paoletti C, Rotella V, Pantalone D, Taddei A, Mercatelli A, Tonelli P. Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study. Br J Cancer. 2007;96:1043-1046. [PMID: 17353926 DOI: 10.1038/sj.bjc.6603644] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
459 Pace C, Nardone V, Roma S, Chegai F, Toti L, Manzia TM, Tisone G, Orlacchio A. Evaluation of Contrast-Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma. J Oncol 2019;2019:6089340. [PMID: 31467539 DOI: 10.1155/2019/6089340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
460 Hadden M, Mittal A, Samra J, Zreiqat H, Sahni S, Ramaswamy Y. Mechanically stressed cancer microenvironment: Role in pancreatic cancer progression.BiochimBiophysActa Rev Cancer. 2020;1874:188418. [PMID: 32827581 DOI: 10.1016/j.bbcan.2020.188418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
461 Anupam K, Tusharkant C, Gupta SD, Ranju R. Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis. World J Gastroenterol 2006; 12(37): 6041-6045 [PMID: 17009406 DOI: 10.3748/wjg.v12.i37.6041] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
462 Ha GH, Lee SU, Kang DG, Ha NY, Kim SH, Kim J, Bae JM, Kim JW, Lee CW. Proteome analysis of human stomach tissue: separation of soluble proteins by two-dimensional polyacrylamide gel electrophoresis and identification by mass spectrometry. Electrophoresis 2002;23:2513-24. [PMID: 12210210 DOI: 10.1002/1522-2683(200208)23:15<2513::AID-ELPS2513>3.0.CO;2-W] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
463 Kumar S, Kumari N, Mittal RD, Ghoshal UC. Pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia. Gastric Cancer 2016;19:808-16. [PMID: 26486507 DOI: 10.1007/s10120-015-0550-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
464 Costantini S, Di Bernardo G, Cammarota M, Castello G, Colonna G. Gene expression signature of human HepG2 cell line. Gene 2013;518:335-45. [DOI: 10.1016/j.gene.2012.12.106] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 7.6] [Reference Citation Analysis]
465 Yang Y, Chen Q, Piao HY, Wang B, Zhu GQ, Chen EB, Xiao K, Zhou ZJ, Shi GM, Shi YH, Wu WZ, Fan J, Zhou J, Dai Z. HNRNPAB-regulated lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma. Int J Cancer 2020;146:169-80. [PMID: 31090062 DOI: 10.1002/ijc.32409] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
466 Lambert B, de Klerk JM. Clinical applications of 188Re-labelled radiopharmaceuticals for radionuclide therapy. Nucl Med Commun 2006;27:223-9. [PMID: 16479241 DOI: 10.1097/00006231-200603000-00004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
467 Wakelee HA, Schiller JH. Targeting Angiogenesis with Vascular Endothelial Growth Factor Receptor Small-Molecule Inhibitors: Novel Agents with Potential in Lung Cancer. Clinical Lung Cancer 2005;7:S31-8. [DOI: 10.3816/clc.2005.s.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
468 Dragovich T, McCoy S, Fenoglio-Preiser CM, Wang J, Benedetti JK, Baker AF, Hackett CB, Urba SG, Zaner KS, Blanke CD, Abbruzzese JL. Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127. J Clin Oncol. 2006;24:4922-4927. [PMID: 17050876 DOI: 10.1200/jco.2006.07.1316] [Cited by in Crossref: 230] [Cited by in F6Publishing: 122] [Article Influence: 15.3] [Reference Citation Analysis]
469 Khan MA, Zafaryab M, Mehdi SH, Quadri J, Rizvi MMA. Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies. International Journal of Biological Macromolecules 2017;97:115-22. [DOI: 10.1016/j.ijbiomac.2016.12.090] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
470 Park J, Kim D, Kim J, Kim Y, Kim Y, Nam J. Outcomes after radical hysterectomy according to tumor size divided by 2-cm interval in patients with early cervical cancer. Annals of Oncology 2011;22:59-67. [DOI: 10.1093/annonc/mdq321] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
471 Erkan B, Meier J, Clark TJ, Kaplan J, Lambert JR, Chang S. Non-invasive diagnostic criteria of hepatocellular carcinoma: Comparison of diagnostic accuracy of updated LI-RADS with clinical practice guidelines of OPTN-UNOS, AASLD, NCCN, EASL-EORTC, and KLSCG-NCC. PLoS One 2019;14:e0226291. [PMID: 31821360 DOI: 10.1371/journal.pone.0226291] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
472 Sitek B, Lüttges J, Marcus K, Klöppel G, Schmiegel W, Meyer HE, Hahn SA, Stühler K. Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma. Proteomics 2005;5:2665-79. [PMID: 15924292 DOI: 10.1002/pmic.200401298] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 6.7] [Reference Citation Analysis]
473 Wei S, Hao X, Zhan D, Xiong M, Li K, Chen X, Huang Z. Are surgical indications of Barcelona Clinic Liver Cancer staging classification justified? J Huazhong Univ Sci Technolog Med Sci. 2011;31:637-641. [PMID: 22038353 DOI: 10.1007/s11596-011-0574-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
474 Amarasinghe HK, Johnson NW, Lalloo R, Kumaraarachchi M, Warnakulasuriya S. Derivation and validation of a risk-factor model for detection of oral potentially malignant disorders in populations with high prevalence. Br J Cancer. 2010;103:303-309. [PMID: 20628386 DOI: 10.1038/sj.bjc.6605778] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
475 Kim K, Zang R, Choi SC, Ryu SY, Kim JW. Current status of gynecological cancer in China. J Gynecol Oncol 2009;20:72-6. [PMID: 19590717 DOI: 10.3802/jgo.2009.20.2.72] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
476 Yi Y, Zhang Y, Wei Q, Zhao L, Han J, Song Y, Ding Y, Lu G, Liu J, Ding H, Dai F, Tang X. Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone. Chin J Cancer Res 2014;26:112-8. [PMID: 24653633 DOI: 10.3978/j.issn.1000-9604.2014.02.09] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
477 Spiegelberg D, Kuku G, Selvaraju R, Nestor M. Characterization of CD44 variant expression in head and neck squamous cell carcinomas. Tumour Biol 2014;35:2053-62. [PMID: 24122205 DOI: 10.1007/s13277-013-1272-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
478 Holmström O, Linder N, Lundin M, Moilanen H, Suutala A, Turkki R, Joensuu H, Isola J, Diwan V, Lundin J. Quantification of Estrogen Receptor-Alpha Expression in Human Breast Carcinomas With a Miniaturized, Low-Cost Digital Microscope: A Comparison with a High-End Whole Slide-Scanner. PLoS One 2015;10:e0144688. [PMID: 26659386 DOI: 10.1371/journal.pone.0144688] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
479 Min JW, Kim KI, Kim HA, Kim EK, Noh WC, Jeon HB, Cho DH, Oh JS, Park IC, Hwang SG, Kim JS. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells. Biochem Biophys Res Commun 2013;440:137-42. [PMID: 24051093 DOI: 10.1016/j.bbrc.2013.09.041] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
480 Moreno-acosta P, Molano M, Huertas A, de Gómez MS, Romero A, González M, Mercedes Bravo M, García-carrancá A. A non-radioactive PCR-SSCP analysis allows to distinguish between HPV 16 European and Asian-American variants in squamous cell carcinomas of the uterine cervix in Colombia. Virus Genes 2008;37:22-30. [DOI: 10.1007/s11262-008-0239-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
481 Liu JY, Zhu Q, Li J, Zhao S, Li L. The retrovirus-mediated antisense human telomerase RNA (hTR) gene limits the growth of hepatocellular carcinoma growth in cell culture and animals. Dig Dis Sci 2008;53:1122-30. [PMID: 17932748 DOI: 10.1007/s10620-007-9980-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
482 Erwin DP, Erwin DO, Ciupak G, Hellenthal N, Sofi MJ, Guru KA, Edge SB. Challenges and implementation of a women's breast health initiative in rural Kashmir. Breast 2011;20 Suppl 2:S46-50. [PMID: 21324696 DOI: 10.1016/j.breast.2011.02.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
483 Sherif RN, Abdellatif H, Hazem N, Ebrahim NA, Saleh D, Shiha G, Eltahry H, Botros KG, Gabr OM. Effect of human umbilical cord blood derived CD34 + hematopoietic stem cell on the expression of Wnt4 and P53 genes in a rat model of hepatocellular carcinoma. Tissue and Cell 2018;50:125-32. [DOI: 10.1016/j.tice.2018.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
484 Smoot RL, Nagorney DM, Chandan VS, Que FG, Schleck CD, Harmsen WS, Kendrick ML. Resection of hepatocellular carcinoma in patients without cirrhosis. Br J Surg. 2011;98:697-703. [PMID: 21280030 DOI: 10.1002/bjs.7401] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
485 Córdova-Rivas S, Araujo-Huitrado JG, Rivera-Avalos E, Escalante-García IL, Durón-Torres SM, López-Hernández Y, Hernández-López H, López L, de Loera D, López JA. Differential Proliferation Effect of the Newly Synthesized Valine, Tyrosine and Tryptophan-Naphthoquinones in Immortal and Tumorigenic Cervical Cell Lines. Molecules 2020;25:E2058. [PMID: 32354078 DOI: 10.3390/molecules25092058] [Reference Citation Analysis]
486 Wysocki PJ. Targeted therapy of hepatocellular cancer. Expert Opinion on Investigational Drugs 2010;19:265-74. [DOI: 10.1517/13543780903514110] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
487 Renganathan L, Ramasubramaniam S, Al-Touby S, Seshan V, Al-Balushi A, Al-Amri W, Al-Nasseri Y, Al-Rawahi Y. What do Omani Women know about Breast Cancer Symptoms? Oman Med J 2014;29:408-13. [PMID: 25584157 DOI: 10.5001/omj.2014.110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
488 Leemans WF, Ter Borg MJ, de Man RA. Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis B. Aliment Pharmacol Ther 2007;26 Suppl 2:171-82. [PMID: 18081660 DOI: 10.1111/j.1365-2036.2007.03481.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
489 Ng KK, Vauthey J, Pawlik TM, Lauwers GY, Regimbeau J, Belghiti J, Ikai I, Yamaoka Y, Curley SA, Nagorney DM, Ng IO, Fan ST, Poon RT. Is Hepatic Resection for Large or Multinodular Hepatocellular Carcinoma Justified? Results From a Multi-Institutional Database. Ann Surg Oncol 2005;12:364-73. [DOI: 10.1245/aso.2005.06.004] [Cited by in Crossref: 167] [Cited by in F6Publishing: 81] [Article Influence: 10.4] [Reference Citation Analysis]
490 Davarpanah AH, Weinreb JC. The role of imaging in hepatocellular carcinoma: the present and future. J Clin Gastroenterol. 2013;47 Suppl:S7-10. [PMID: 23632342 DOI: 10.1097/mcg.0b013e31827f0d3d] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
491 Wang H, Pan K, Zhang HK, Weng DS, Zhou J, Li JJ, Huang W, Song HF, Chen MS, Xia JC. Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2008;134:535-541. [PMID: 17917742 DOI: 10.1007/s00432-007-0316-8] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 5.3] [Reference Citation Analysis]
492 Lee K, Shen M, Chapman RS, Yeager M, Welch R, He X, Zheng T, Hosgood HD, Yang D, Berndt SI, Chanock S, Lan Q. Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis 2007;28:1437-41. [DOI: 10.1093/carcin/bgm030] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
493 Yau T, Chan P, Wong H, Ng KK, Chok S, Cheung T, Lam V, Epstein RJ, Fan S, Poon RT. Efficacy and Tolerability of Low-Dose Thalidomide as First-Line Systemic Treatment of Patients with Advanced Hepatocellular Carcinoma. Oncology 2007;72:67-71. [DOI: 10.1159/000111709] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
494 Ni J, Liu S, Xu L, Sun H, Chen Y. Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 2013;139:653-9. [DOI: 10.1007/s00432-012-1369-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
495 Kornberger A, Emrich T, Beiras-Fernandez A, Vahl CF. Restrictive surgical approach to palliate angina in a patient with coronary three vessel disease and biventricular metastatic hepatocellular carcinoma. World J Surg Oncol 2017;15:217. [PMID: 29212547 DOI: 10.1186/s12957-017-1256-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
496 Imai K, Beppu T, Chikamoto A, Mima K, Okabe H, Hayashi H, Nitta H, Ishiko T, Baba H. Salvage treatment for local recurrence of hepatocellular carcinoma after local ablation therapy: Salvage for local recurrence of HCC. Hepatol Res 2014;44:E335-45. [DOI: 10.1111/hepr.12313] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
497 Mountzios G, Ramfidis V, Terpos E, Syrigos KN. Prognostic significance of bone markers in patients with lung cancer metastatic to the skeleton: a review of published data. Clin Lung Cancer 2011;12:341-9. [PMID: 21703936 DOI: 10.1016/j.cllc.2011.03.032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
498 Someya T, Ikeda K, Saitoh S, Kobayashi M, Hosaka T, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis. J Gastroenterol 2006;41:1206-13. [PMID: 17287900 DOI: 10.1007/s00535-006-1912-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
499 He C, Xu C, Xu M, Yuan Y, Sun Y, Zhao H, Zhang X. Genomic amplification of hTERC in paraffin-embedded tissues of cervical intraepithelial neoplasia and invasive cancer. Int J Gynecol Pathol 2012;31:280-5. [PMID: 22498947 DOI: 10.1097/PGP.0b013e318237d50a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
500 Kim HA, Yom CK, Moon BI, Choe KJ, Sung SH, Han WS, Choi HY, Kim HK, Park HK, Choi SH. The use of an in vitro adenosine triphosphate-based chemotherapy response assay to predict chemotherapeutic response in breast cancer. Breast. 2008;17:19-26. [PMID: 17659874 DOI: 10.1016/j.breast.2007.06.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
501 Gårdmark T, Jahnson S, Wahlquist R, Wijkström H, Malmström P. Analysis of progression and survival after 10 years of a randomized prospective study comparing mitomycin-C and bacillus Calmette-Guérin in patients with high-risk bladder cancer: PROGRESSION AND SURVIVAL AFTER 10 YEARS IN A STUDY OF MMC VS BCG IN HIGH-RISK BLADDER CANCER. BJU International 2007;99:817-20. [DOI: 10.1111/j.1464-410x.2006.06706.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
502 Girón RA, Montaño LF, Escobar ML, López-Marure R. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism. FEBS J 2009;276:5598-609. [PMID: 19702826 DOI: 10.1111/j.1742-4658.2009.07253.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
503 Kavoosi F, Dastjerdi MN, Valiani A, Esfandiari E, Sanaei M, Hakemi MG. Genistein potentiates the effect of 17-beta estradiol on human hepatocellular carcinoma cell line. Adv Biomed Res 2016;5:133. [PMID: 27656602 DOI: 10.4103/2277-9175.187395] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
504 Villagómez-ortíz VJ, Paz-delgadillo DE, Marino-martínez I, Ceseñas-falcón LÁ, Sandoval-de la Fuente A, Reyes-escobedo A. Prevalencia de infección por virus del papiloma humano en carcinoma espinocelular de cavidad oral, orofaringe y laringe. Cirugía y Cirujanos 2016;84:363-8. [DOI: 10.1016/j.circir.2016.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
505 Pichon-riviere A, Augustovski F, Bardach A, Colantonio L. Development and Validation of a Microsimulation Economic Model to Evaluate the Disease Burden Associated with Smoking and the Cost-Effectiveness of Tobacco Control Interventions in Latin America. Value in Health 2011;14:S51-9. [DOI: 10.1016/j.jval.2011.05.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
506 Upender S, Mohan H, Handa U, Attri AK. Intraoperative evaluation of sentinel lymph nodes in breast carcinoma by imprint cytology, frozen section and rapid immunohistochemistry. Diagn Cytopathol 2009;37:871-5. [DOI: 10.1002/dc.21120] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
507 Gridelli C. Targeted therapies and non-small-cell lung cancer: new developments. Current Opinion in Oncology 2007;19:75-7. [DOI: 10.1097/cco.0b013e328012a05b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
508 Shah PP, Singh AP, Singh M, Mathur N, Mishra BN, Pant MC, Parmar D. Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer. Mutat Res 2008;643:4-10. [PMID: 18573508 DOI: 10.1016/j.mrfmmm.2008.05.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
509 Song YJ, Kim J, Lee S, Lim H, Lim MC, Seo S, Kang S, Lee DO, Park S. Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer. Int J Cancer 2011;129:896-902. [DOI: 10.1002/ijc.25741] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
510 Mikoshiba N, Tateishi R, Tanaka M, Sakai T, Blazeby JM, Kokudo N, Koike K, Kazuma K. Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18). Health Qual Life Outcomes 2012;10:58. [PMID: 22651810 DOI: 10.1186/1477-7525-10-58] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
511 Frederick MJ, VanMeter AJ, Gadhikar MA, Henderson YC, Yao H, Pickering CC, Williams MD, El-Naggar AK, Sandulache V, Tarco E, Myers JN, Clayman GL, Liotta LA, Petricoin EF 3rd, Calvert VS, Fodale V, Wang J, Weber RS. Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples. Am J Pathol 2011;178:548-71. [PMID: 21281788 DOI: 10.1016/j.ajpath.2010.10.044] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
512 Hosseini BA, Pasdaran A, Kazemi T, Shanehbandi D, Karami H, Orangi M, Baradaran B. Dichloromethane fractions of Scrophularia oxysepala extract induce apoptosis in MCF-7 human breast cancer cells. Bosn J Basic Med Sci 2015;15:26-32. [PMID: 25725141 DOI: 10.17305/bjbms.2015.1.226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
513 Vaiphei K, Kochhar R, Bhardawaj S, Dutta U, Singh K. High prevalence of human papillomavirus in esophageal squamous cell carcinoma: a study in paired samples. Dis Esophagus. 2013;26:282-287. [PMID: 22676445 DOI: 10.1111/j.1442-2050.2012.01365.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
514 Kokalj-Vokac N, Kodric T, Erjavec-Skerget A, Zagorac A, Takac I. Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions. Cancer Genet Cytogenet 2009;195:19-22. [PMID: 19837263 DOI: 10.1016/j.cancergencyto.2009.01.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
515 DeAngelis A, Breik O, Koo K, Iseli T, Nastri A, Fua T, Rischin D, McCullough M, Wiesenfeld D. Non-smoking, non-drinking elderly females, a 5 year follow-up of a clinically distinct cohort of oral squamous cell carcinoma patients. Oral Oncol 2018;86:113-20. [PMID: 30409291 DOI: 10.1016/j.oraloncology.2018.09.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
516 Schettino C, Bareschino MA, Maione P, Rossi A, Ciardiello F, Gridelli C. The potential role of pharmacogenomic and genomic in the adjuvant treatment of early stage non small cell lung cancer. Curr Genomics 2008;9:252-62. [PMID: 19452042 DOI: 10.2174/138920208784533665] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
517 Heijstek MW, Kranenburg O, Borel Rinkes IH. Mouse models of colorectal cancer and liver metastases. Dig Surg. 2005;22:16-25. [PMID: 15838167 DOI: 10.1159/000085342] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 4.6] [Reference Citation Analysis]
518 Zeng Z, Ren J, O’Neil M, Zhao J, Bridges B, Cox J, Abdulkarim B, Schmitt TM, Kumer SC, Weinman SA. Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation. BMC Cancer. 2012;12:584. [PMID: 23216644 DOI: 10.1186/1471-2407-12-584] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
519 Pez F, Lopez A, Kim M, Wands JR, Caron de Fromentel C, Merle P. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. J Hepatol 2013;59:1107-17. [PMID: 23835194 DOI: 10.1016/j.jhep.2013.07.001] [Cited by in Crossref: 172] [Cited by in F6Publishing: 161] [Article Influence: 21.5] [Reference Citation Analysis]
520 Dufresne A, Pivot X, Tournigand C, Facchini T, Altweegg T, Chaigneau L, De Gramont A. Impact of chemotherapy beyond the first line in patients with metastatic breast cancer. Breast Cancer Res Treat 2008;107:275-9. [DOI: 10.1007/s10549-007-9550-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
521 Lopez PM, Villanueva A, Roayaie S, Llovet JM. Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal. Liver Transpl. 2006;12:1747-1754. [PMID: 17133591 DOI: 10.1002/lt.21018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
522 Tanaka M, Ando E, Simose S, Hori M, Kuraoka K, Ohno M, Yutani S, Harada K, Sata M. Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinoma. Hepatol Res. 2014;44:194-200. [PMID: 23521520 DOI: 10.1111/hepr.12100] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
523 Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007;608:1-22. [PMID: 17993229 DOI: 10.1007/978-0-387-74039-3_1] [Cited by in Crossref: 505] [Cited by in F6Publishing: 479] [Article Influence: 36.1] [Reference Citation Analysis]
524 Hai B, Yang Z, Millar SE, Choi YS, Taketo MM, Nagy A, Liu F. Wnt/β-catenin signaling regulates postnatal development and regeneration of the salivary gland. Stem Cells Dev 2010;19:1793-801. [PMID: 20367250 DOI: 10.1089/scd.2009.0499] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
525 Khan AS, Fowler KJ, Chapman WC. Current surgical treatment strategies for hepatocellular carcinoma in North America. World J Gastroenterol 2014; 20(41): 15007-15017 [PMID: 25386049 DOI: 10.3748/wjg.v20.i41.15007] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
526 Prasad CP, Gupta SD, Rath G, Ralhan R. Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression. Oncology. 2007;73:112-117. [PMID: 18337623 DOI: 10.1159/000120999] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 4.5] [Reference Citation Analysis]
527 Jensen BT, Dielenseger P, Drudge-coates L, Flynn K, Hieronymi S, (Erik) van Muilekom H, Pieters R, Voss LB. Taking the lead – Sharing best practice in intravenous bisphosphonate use in urological cancers. European Journal of Oncology Nursing 2012;16:42-53. [DOI: 10.1016/j.ejon.2011.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
528 Colantonio L, Gómez JA, Demarteau N, Standaert B, Pichón-rivière A, Augustovski F. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries. Vaccine 2009;27:5519-29. [DOI: 10.1016/j.vaccine.2009.06.097] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
529 Chung MCM, Liang RCMY, Seow TK, Neo JCH, Lo SL, Tan GS. Proteomics of Hepatocellular Carcinoma: Present Status and Future Prospects. In: Hondermarck H, editor. Proteomics: Biomedical and Pharmaceutical Applications. Dordrecht: Kluwer Academic Publishers; 2004. pp. 163-81. [DOI: 10.1007/1-4020-2323-5_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
530 Leichsenring J, Stögbauer F, Volckmar A, Buchhalter I, Oliveira C, Kirchner M, Fröhling S, Hassel J, Enk A, Schirmacher P, Endris V, Penzel R, Stenzinger A. Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 cases. Pathology 2018;50:703-10. [DOI: 10.1016/j.pathol.2018.08.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
531 Mcclune AC, Tong MJ. Is the Search for a Single Comprehensive Staging System for Hepatocellular Carcinoma an Elusive One? Journal of Clinical Gastroenterology 2009;43:697-8. [DOI: 10.1097/mcg.0b013e3181acec0c] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
532 Stecco A, Buemi F, Cassarà A, Matheoud R, Sacchetti GM, Arnulfo A, Brambilla M, Carriero A. Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases. Radiol Med 2016;121:537-45. [PMID: 27033474 DOI: 10.1007/s11547-016-0626-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
533 Cottier O, Sahli R, Mihaescu A, De Grandi P, Boulvain M, Gerber S. Clinical follow-up of women infected with human papillomavirus-16, either alone or with other human papillomavirus types: identification of different risk groups. American Journal of Obstetrics and Gynecology 2009;200:286.e1-6. [DOI: 10.1016/j.ajog.2008.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
534 Lin FY, Hsieh YH, Yang SF, Chen CT, Tang CH, Chou MY, Chuang YT, Lin CW, Chen MK. Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells. J Oral Pathol Med 2015;44:699-706. [PMID: 25401496 DOI: 10.1111/jop.12288] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
535 Dong Y, Liu S, Shen Y, He H, Ma H. Probing variations of fibrous structures during the development of breast ductal carcinoma tissues via Mueller matrix imaging. Biomed Opt Express 2020;11:4960-75. [PMID: 33014593 DOI: 10.1364/BOE.397441] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
536 Chen HY, Ma XM, Ye M, Hou YL, Hu B, Bai YR. CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation. J Radiat Res 2013;54:938-42. [PMID: 23616629 DOI: 10.1093/jrr/rrt030] [Reference Citation Analysis]
537 Belhocine T, Thille A, Fridman V, Albert A, Seidel L, Nickers P, Kridelka F, Rigo P. Contribution of Whole-Body 18FDG PET Imaging in the Management of Cervical Cancer. Gynecologic Oncology 2002;87:90-7. [DOI: 10.1006/gyno.2002.6769] [Cited by in Crossref: 89] [Cited by in F6Publishing: 66] [Article Influence: 4.7] [Reference Citation Analysis]
538 Wong CC, Wong CM, Au SL, Ng IO. RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N'Rho move it. Liver Int. 2010;30:642-656. [PMID: 20726051 DOI: 10.1111/j.1478-3231.2010.02232.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
539 Wang T, Li Y, Wang W, Tuerhanjiang A, Wu Z, Yang R, Yuan M, Ma D, Wang W, Wang S. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence. Hum Pathol 2014;45:1839-46. [PMID: 24974259 DOI: 10.1016/j.humpath.2014.05.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
540 Theodoropoulos J, Brooks A. Inconsistency in the Management of Patients with Hepatocellular Carcinoma: The Need for a Strict Protocol. The American Surgeon 2011;77:207-14. [DOI: 10.1177/000313481107700223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
541 Bruix J. HCC surveillance: Who is the target population? Hepatology 2003;37:507-9. [DOI: 10.1053/jhep.2003.50142] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
542 Khedri A, Nejat-shokouhi A, Salek R, Esmaeili H, Mokhtarifar A, Entezari Heravi R, Tatari F, Behravan J, Miladpour B, Omidvar Tehrani S. Association of the colorectal cancer and MDR1 gene polymorphism in an Iranian population. Mol Biol Rep 2011;38:2939-43. [DOI: 10.1007/s11033-010-9957-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
543 Takayasu K, Muramatsu Y, Mizuguchi Y, Ojima H. CT Imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver disease. Oncology. 2007;72 Suppl 1:83-91. [PMID: 18087187 DOI: 10.1159/000111712] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
544 Choi CS, Kim KH, Seo GS, Cho EY, Oh HJ, Choi SC, Kim TH, Kim HC, Roh BS. Cerebral and pulmonary embolisms after transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2008; 14(30): 4834-4837 [PMID: 18720550 DOI: 10.3748/wjg.14.4834] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
545 Sivridis E, Giatromanolaki A, Galazios G, Koukourakis MI. Node-related factors and survival in node-positive breast carcinomas. Breast 2006;15:382-9. [PMID: 16135406 DOI: 10.1016/j.breast.2005.06.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
546 Mehendiratta M, Solomon MC, Boaz K, Guddattu V, Mohindra A. Clinico-pathological correlation of E-cadherin expression at the invasive tumor front of Indian oral squamous cell carcinomas: An immunohistochemical study. J Oral Maxillofac Pathol 2014;18:217-22. [PMID: 25328302 DOI: 10.4103/0973-029X.140753] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
547 Chung HH, Kim SK, Kim TH, Lee S, Kang KW, Kim JY, Park SY. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. Gynecol Oncol 2006;103:165-70. [PMID: 16574205 DOI: 10.1016/j.ygyno.2006.02.016] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
548 Afzal M, Bhardwaj DP, Khan R, Kazmi I, Saleem S, Al-abbasi FA, Anwar F. Antineoplastic influence of nimesulide in chemically induced hepatocellular carcinoma by inhibition of DNA synthesis. Inflammopharmacol 2019;27:89-98. [DOI: 10.1007/s10787-018-0481-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
549 Loganathan R, Selvaduray KR, Nesaretnam K, Radhakrishnan AK. Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity. Cell Prolif 2013;46:203-13. [PMID: 23510475 DOI: 10.1111/cpr.12014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
550 Craxì A, Cammà C. Prevention of hepatocellular carcinoma. Clin Liver Dis 2005;9:329-46, viii. [PMID: 15831277 DOI: 10.1016/j.cld.2004.12.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
551 Kamath SD, D'souza CS, Mathew S, George SD, Santhosh C, Mahato KK. A pilot study on colonic mucosal tissues by fluorescence spectroscopy technique: Discrimination by principal component analysis (PCA) and artificial neural network (ANN) analysis. J Chemometrics 2008;22:408-16. [DOI: 10.1002/cem.1154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
552 Robertson JH, Yang SY, Winslet MC, Seifalian AM. Functional blocking of specific integrins inhibit colonic cancer migration. Clin Exp Metastasis 2009;26:769-80. [PMID: 19557530 DOI: 10.1007/s10585-009-9276-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
553 Sitek B, Sipos B, Alkatout I, Poschmann G, Stephan C, Schulenborg T, Marcus K, Lüttges J, Dittert DD, Baretton G. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation. J Proteome Res. 2009;8:1647-1656. [PMID: 19714807 DOI: 10.1021/pr800890j] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
554 Serrano M, Sánchez-gómez M, Bravo M. Insulin-like growth factor system gene expression in cervical scrapes from women with squamous intraepithelial lesions and cervical cancer. Growth Hormone & IGF Research 2007;17:492-9. [DOI: 10.1016/j.ghir.2007.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
555 Israels T, Ribeiro RC, Molyneux EM. Strategies to improve care for children with cancer in Sub-Saharan Africa. Eur J Cancer. 2010;46:1960-1966. [PMID: 20403685 DOI: 10.1016/j.ejca.2010.03.027] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
556 Clark T, Barton P, Coomarasamy A, Gupta J, Khan K. Gynaecological oncology: Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies. BJOG: An International Journal of Obstetrics & Gynaecology 2006;113:502-10. [DOI: 10.1111/j.1471-0528.2006.00914.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 4.9] [Reference Citation Analysis]
557 Carr SD, Green VL, Stafford ND, Greenman J. Analysis of radiation-induced cell death in head and neck squamous cell carcinoma and rat liver maintained in microfluidic devices. Otolaryngol Head Neck Surg 2014;150:73-80. [PMID: 24098006 DOI: 10.1177/0194599813507427] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
558 Li YP, Wu CC, Chen WT, Huang YC, Chai CY. The expression and significance of WWOX and β-catenin in hepatocellular carcinoma. APMIS. 2013;121:120-126. [PMID: 23030478 DOI: 10.1111/j.1600-0463.2012.02947.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
559 Qi D, Wu C, Liu F, Gu K, Shi Z, Lin X, Tao S, Xu W, Brendler CB, Zheng Y, Xu J. Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009. Prostate 2015;75:1662-8. [PMID: 26184773 DOI: 10.1002/pros.23046] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
560 Lopez-Graniel C, Dolores R, Cetina L, Gonzalez A, Cantu D, Chanona J, Uribe J, Candelaria M, Brom R, de la Garza J, Duenas-Gonzalez A. Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer. BMC Cancer 2005;5:118. [PMID: 16171526 DOI: 10.1186/1471-2407-5-118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
561 Durczak M, Jagodzinski PP. Apicidin upregulates PHD2 prolyl hydroxylase gene expression in cervical cancer cells. Anticancer Drugs 2010;21:619-24. [PMID: 20527723 DOI: 10.1097/cad.0b013e328339848b] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
562 Pinter M, Wichlas M, Schmid K, Plank C, Müller C, Wrba F, Peck-radosavljevic M. Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial: . European Journal of Gastroenterology & Hepatology 2008;20:1012-9. [DOI: 10.1097/meg.0b013e3283036740] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
563 Ishikawa E, Sugimoto H, Hatano M, Nakanishi Y, Tsuji A, Endo K, Kondo S, Wakisaka N, Murono S, Ito M, Yoshizaki T. Protective effects of sodium thiosulfate for cisplatin-mediated ototoxicity in patients with head and neck cancer. Acta Otolaryngol 2015;135:919-24. [PMID: 25861690 DOI: 10.3109/00016489.2015.1035797] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
564 Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Sato T, Masuzaki R, Kondo Y, Goto T, Yoshida H, Omata M, Koike K. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107:569-77; quiz 578. [PMID: 22158026 DOI: 10.1038/ajg.2011.425] [Cited by in Crossref: 406] [Cited by in F6Publishing: 385] [Article Influence: 40.6] [Reference Citation Analysis]
565 Parmiani G, Anichini A. T cell infiltration and prognosis in HCC patients. Journal of Hepatology 2006;45:178-81. [DOI: 10.1016/j.jhep.2006.06.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
566 Grande E, Inghelmann R, Francisci S, Verdecchia A, Micheli A, Baili P, Capocaccia R, De Angelis R. Regional Estimates of Colorectal Cancer Burden in Italy. Tumori 2007;93:352-9. [DOI: 10.1177/030089160709300405] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
567 Büchler MW, Kleeff J, Friess H. Surgical treatment of pancreatic cancer. J Am Coll Surg 2007;205:S81-6. [PMID: 17916525 DOI: 10.1016/j.jamcollsurg.2007.06.332] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
568 Mohs A, Kuttkat N, Reißing J, Zimmermann HW, Sonntag R, Proudfoot A, Youssef SA, de Bruin A, Cubero FJ, Trautwein C. Functional role of CCL5/RANTES for HCC progression during chronic liver disease. J Hepatol 2017;66:743-53. [PMID: 28011329 DOI: 10.1016/j.jhep.2016.12.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
569 Patil MA, Chua MS, Pan KH, Lin R, Lih CJ, Cheung ST, Ho C, Li R, Fan ST, Cohen SN, Chen X, So S. An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Oncogene 2005;24:3737-47. [PMID: 15735714 DOI: 10.1038/sj.onc.1208479] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 5.3] [Reference Citation Analysis]
570 Pinto D, Pereira D, Portela C, da Silva JL, Lopes C, Medeiros R. The influence of HER2 genotypes as molecular markers in ovarian cancer outcome. Biochem Biophys Res Commun. 2005;335:1173-1178. [PMID: 16112085 DOI: 10.1016/j.bbrc.2005.08.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
571 Kang S, Dong SM, Park NH. Frequent promoter hypermethylation of TGFBI in epithelial ovarian cancer. Gynecol Oncol 2010;118:58-63. [PMID: 20421128 DOI: 10.1016/j.ygyno.2010.03.025] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
572 Seiwert TY, Salama JK, Vokes EE. The chemoradiation paradigm in head and neck cancer. Nat Clin Pract Oncol 2007;4:156-71. [PMID: 17327856 DOI: 10.1038/ncponc0750] [Cited by in Crossref: 158] [Cited by in F6Publishing: 142] [Article Influence: 11.3] [Reference Citation Analysis]
573 Rakha EA, El-sayed ME, Reis-filho JS, Ellis IO. Expression profiling technology: its contribution to our understanding of breast cancer: An overview of breast cancer array technology. Histopathology 2008;52:67-81. [DOI: 10.1111/j.1365-2559.2007.02894.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
574 Masuzaki R, Yoshida H, Kato N, Omata M. Hepatitis C and Hepatocellular Carcinoma. In: Carr BI, editor. Hepatocellular Carcinoma. Totowa: Humana Press; 2010. pp. 259-81. [DOI: 10.1007/978-1-60327-376-3_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
575 Li W, Deng X, Wang C, Zhang X, Zheng G, Zhang J, Feng J. Down-Regulation of HLA Class I Antigen in Human Papillomavirus Type 16 E7 Expressing HaCaT Cells: Correlate With TAP-1 Expression. International Journal of Gynecological Cancer 2010;20:227-32. [DOI: 10.1111/igc.0b013e3181cceec5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
576 Yue PY, Wong YY, Wong KY, Tsoi YK, Leung KS. Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea. Chin Med 2013;8:21. [PMID: 24180549 DOI: 10.1186/1749-8546-8-21] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
577 Le Deley MC, Suzan F, Cutuli B, Delaloge S, Shamsaldin A, Linassier C, Clisant S, de Vathaire F, Fenaux P, Hill C. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. J Clin Oncol. 2007;25:292-300. [PMID: 17159192 DOI: 10.1200/jco.2006.05.9048] [Cited by in Crossref: 109] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
578 Blais N, Corrales-Rodriguez L. Personalized choice of maintenance therapies in non-small-cell lung cancer. Curr Oncol 2012;19:S64-72. [PMID: 22787413 DOI: 10.3747/co.19.1068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
579 Gurtsevitch VE. Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Mosc). 2008;73:504-513. [PMID: 18605975 DOI: 10.1134/s0006297908050039] [Cited by in Crossref: 54] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
580 Lange N, Tontsa AT, Wegscheid C, Mkounga P, Nkengfack AE, Loscher C, Sass G, Tiegs G. The Limonoids TS3 and Rubescin E Induce Apoptosis in Human Hepatoma Cell Lines and Interfere with NF-κB Signaling. PLoS One 2016;11:e0160843. [PMID: 27518192 DOI: 10.1371/journal.pone.0160843] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
581 Urman CO, Gottlieb AB. New viral vaccines for dermatologic disease. Journal of the American Academy of Dermatology 2008;58:361-70. [DOI: 10.1016/j.jaad.2007.07.051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
582 Jarnagin WR. Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation. Ann Surg Oncol. 2010;17:1226-1233. [PMID: 20405327 DOI: 10.1245/s10434-010-0978-3.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
583 Song MJ, Chun HJ, Song DS, Kim HY, Yoo SH, Park CH, Bae SH, Choi JY, Chang UI, Yang JM, Lee HG, Yoon SK. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol. 2012;57:1244-1250. [PMID: 22824821 DOI: 10.1016/j.jhep.2012.07.017] [Cited by in Crossref: 135] [Cited by in F6Publishing: 141] [Article Influence: 15.0] [Reference Citation Analysis]
584 Yoon SK. Recent advances in tumor markers of human hepatocellular carcinoma. Intervirology. 2008;51 Suppl 1:34-41. [PMID: 18544946 DOI: 10.1159/000122596] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
585 Zhou Y, Li N, Zhuang W, Wu X. Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a Chinese Han population. Mol Carcinog. 2011;50:184-188. [PMID: 21344505 DOI: 10.1002/mc.20703] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
586 Shinozaki K, Ebert O, Woo SL. Eradication of advanced hepatocellular carcinoma in rats via repeated hepatic arterial infusions of recombinant VSV. Hepatology. 2005;41:196-203. [PMID: 15619242 DOI: 10.1002/hep.20536] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
587 Lu X, Monnier-benoit S, Mo L, Xu S, Prétet J, Liu Z, Vuitton D, Mougin C. Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. European Journal of Surgical Oncology (EJSO) 2008;34:765-70. [DOI: 10.1016/j.ejso.2007.11.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
588 Chakraborty S, Das T, Sarma HD, Venkatesh M, Banerjee S. Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer. Nucl Med Biol 2008;35:589-97. [PMID: 18589303 DOI: 10.1016/j.nucmedbio.2008.03.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
589 Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004;364:1757-1765. [PMID: 15541448 DOI: 10.1016/s0140-6736(04)17398-4] [Cited by in Crossref: 1109] [Cited by in F6Publishing: 331] [Article Influence: 65.2] [Reference Citation Analysis]
590 Xu Y, Chen J, Wang H, Zheng H, Feng D, Zhang A, Leng J, Duan W, Yang Z, Chen M, Shi X, Cai S, Ji W, Jiang K, Zhang W, Chen Y, Gu W, Dong J, Lu S. Perioperative and long-term outcomes of liver resection for hepatitis B virus-related hepatocellular carcinoma without versus with hepatic inflow occlusion: study protocol for a prospective randomized controlled trial. Trials 2016;17:492. [PMID: 27724929 DOI: 10.1186/s13063-016-1621-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
591 Nkili-Meyong AA, Moussavou-Boundzanga P, Labouba I, Koumakpayi IH, Jeannot E, Descorps-Declère S, Sastre-Garau X, Leroy EM, Belembaogo E, Berthet N. Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology. Sci Rep 2019;9:1504. [PMID: 30728408 DOI: 10.1038/s41598-018-37871-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
592 Tahara T, Arisawa T, Shibata T, Wang FY, Nakamura M, Sakata M, Nagasaka M, Takagi T, Kamiya Y, Fujita H. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Digestion. 2007;75:54-61. [PMID: 17438355 DOI: 10.1159/000101775] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
593 Mohammed ZM, McMillan DC, Elsberger B, Going JJ, Orange C, Mallon E, Doughty JC, Edwards J. Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer. Br J Cancer 2012;106:383-8. [PMID: 22251968 DOI: 10.1038/bjc.2011.569] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 7.2] [Reference Citation Analysis]
594 Dieye M, Veronique-Baudin J, Draganescu C, Azaloux H. Cancer incidence in Martinique: a model of epidemiological transition. Eur J Cancer Prev 2007;16:95-101. [PMID: 17297384 DOI: 10.1097/01.cej.0000236246.78736.51] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
595 Requena T, Martín MT, Desongles T, Castillo I, Lorente L, Yébenes M; and the EUPTHEA Group. Prescription pattern for antivirals in the treatment of chronic hepatitis B: the EUPTHEA Study. Eur J Hosp Pharm 2013;20:174-9. [DOI: 10.1136/ejhpharm-2012-000206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
596 Shrikhande SV, Kleeff J, Reiser C, Weitz J, Hinz U, Esposito I, Schmidt J, Friess H, Büchler MW. Pancreatic Resection for M1 Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 2006;14:118-27. [DOI: 10.1245/s10434-006-9131-8] [Cited by in Crossref: 135] [Cited by in F6Publishing: 119] [Article Influence: 9.0] [Reference Citation Analysis]
597 Yoon YJ, Han K, Kim DY. Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Scandinavian Journal of Gastroenterology 2009;44:861-6. [DOI: 10.1080/00365520902903034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
598 Coelho G, Vasconcelos K, Vasconcelos J, Barros M, Costa P, Borges G, Júnior J, Brasil I, Filho D, Viana C, Rocha T, Mesquita D, Garcia J. Orthotopic Liver Transplantation for Hepatocellular Carcinoma: One Center's Experience in the Northeast of Brazil. Transplantation Proceedings 2009;41:1740-2. [DOI: 10.1016/j.transproceed.2009.01.104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
599 Huang M, Huang S, Li D, Nie X, Li H, Jiang X. The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions. Med Oncol 2011;28:547-52. [DOI: 10.1007/s12032-010-9705-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
600 Wong LP, Sam I. Ethnically diverse female university students’ knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology 2010;148:90-5. [DOI: 10.1016/j.ejogrb.2009.10.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
601 Vergara Gómez M, Miquel Planas M, Gil Prades M, Dalmau Obrador B, Casas Rodrigo M, Sanchez Delgado J, Bella MR, Puig Domingo J. [Rapid progression of hepatocellular carcinoma after surgery: apropos of a case and review of the literature]. Gastroenterol Hepatol 2010;33:569-73. [PMID: 20627456 DOI: 10.1016/j.gastrohep.2010.03.008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
602 Pollom EL, Lee K, Durkee BY, Grade M, Mokhtari DA, Wahl DR, Feng M, Kothary N, Koong AC, Owens DK, Goldhaber-Fiebert J, Chang DT. Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study. Radiology 2017;283:460-8. [PMID: 28045603 DOI: 10.1148/radiol.2016161509] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
603 Kohles N, Nagel D, Jüngst D, Durner J, Stieber P, Holdenrieder S. Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients. BMC Cancer. 2011;11:202. [PMID: 21615953 DOI: 10.1186/1471-2407-11-202] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
604 Yu MH, Kim JH, Yoon J, Kim H, Chung JW, Han JK, Choi B. Small (≤1-cm) Hepatocellular Carcinoma: Diagnostic Performance and Imaging Features at Gadoxetic Acid–enhanced MR Imaging. Radiology 2014;271:748-60. [DOI: 10.1148/radiol.14131996] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 9.0] [Reference Citation Analysis]
605 Zhao L, Zhang Z, Lou H, Liang J, Yan X, Li W, Xu Y, Ou R. Exploration of the molecular mechanisms of cervical cancer based on mRNA expression profiles and predicted microRNA interactions. Oncol Lett 2018;15:8965-72. [PMID: 29805632 DOI: 10.3892/ol.2018.8494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
606 Blas MM, Alva IE, Garcia PJ, Carcamo C, Montano SM, Muñante R, Zunt JR. Association between human papillomavirus and human T-lymphotropic virus in indigenous women from the Peruvian Amazon. PLoS One 2012;7:e44240. [PMID: 22952937 DOI: 10.1371/journal.pone.0044240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
607 He XF, Su J, Zhang Y, Huang X, Liu Y, Ding DP, Wang W, Arparkorn K. Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study. Breast Cancer Res Treat 2011;130:517-29. [PMID: 21604156 DOI: 10.1007/s10549-011-1583-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
608 Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, Ryu Y, Kawai K, Kozaka K. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic Acid-enhanced magnetic resonance imaging findings of borderline lesions at high risk for progression to hypervascular classic hepatocellular carcinoma. J Comput Assist Tomogr. 2011;35:181-186. [PMID: 21412087 DOI: 10.1097/rct.0b013e3182026f3b] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
609 Rybnikova N, Haim A, Portnov BA. Artificial Light at Night (ALAN) and breast cancer incidence worldwide: A revisit of earlier findings with analysis of current trends. Chronobiology International 2015;32:757-73. [DOI: 10.3109/07420528.2015.1043369] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
610 Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer 2003;105:687-91. [PMID: 12740919 DOI: 10.1002/ijc.11141] [Cited by in Crossref: 143] [Cited by in F6Publishing: 126] [Article Influence: 7.9] [Reference Citation Analysis]
611 Arora A, Kotecha J, Acharya A, Garas G, Darzi A, Davies DC, Tolley N. Determination of biometric measures to evaluate patient suitability for transoral robotic surgery: Role of biometrics in determining transoral robotic surgery feasibility. Head Neck 2015;37:1254-60. [DOI: 10.1002/hed.23739] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
612 Fouad SA, Mohamed NA, Fawzy MW, Moustafa DA. Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma. Hepat Mon 2015;15:e30753. [PMID: 26500684 DOI: 10.5812/hepatmon.30753] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
613 Orabi KY, Abaza MS, El Sayed KA, Elnagar AY, Al-Attiyah R, Guleri RP. Selective growth inhibition of human malignant melanoma cells by syringic acid-derived proteasome inhibitors. Cancer Cell Int 2013;13:82. [PMID: 23958424 DOI: 10.1186/1475-2867-13-82] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
614 Grasso M. Bladder Cancer: A Major Public Health Issue. European Urology Supplements 2008;7:510-5. [DOI: 10.1016/j.eursup.2008.04.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
615 Mathur A, Franco ES, Leone JP, Osman-Mohamed H, Rojas H, Kemmer N, Neff GW, Rosemurgy AS, Alsina AE. Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma. HPB (Oxford). 2013;15:504-510. [PMID: 23750492 DOI: 10.1111/j.1477-2574.2012.00602.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
616 Nam JH, Park JY, Kim DY, Kim JH, Kim YM, Kim YT. Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study. Ann Oncol 2012;23:903-11. [PMID: 21841155 DOI: 10.1093/annonc/mdr360] [Cited by in Crossref: 140] [Cited by in F6Publishing: 123] [Article Influence: 14.0] [Reference Citation Analysis]
617 Wang W, Feng X, Zhang T, Jin J, Wang S, Liu Y, Song Y, Liu X, Yu Z, Li Y. Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy. Radiat Oncol 2010;5:73. [PMID: 20731853 DOI: 10.1186/1748-717X-5-73] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
618 Matsubara T, Kanto T, Kuroda S, Yoshio S, Higashitani K, Kakita N, Miyazaki M, Sakakibara M, Hiramatsu N, Kasahara A, Tomimaru Y, Tomokuni A, Nagano H, Hayashi N, Takehara T. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis. Hepatology. 2013;57:1416-1425. [PMID: 22815256 DOI: 10.1002/hep.25965] [Cited by in Crossref: 81] [Cited by in F6Publishing: 88] [Article Influence: 10.1] [Reference Citation Analysis]
619 Geng YJ, Xie SL, Li Q, Ma J, Wang GY. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res. 2011;39:2119-2128. [PMID: 22289527 DOI: 10.1177/147323001103900608] [Cited by in Crossref: 260] [Cited by in F6Publishing: 275] [Article Influence: 28.9] [Reference Citation Analysis]
620 Chen M, Yang X, Yang M, Zhang W, Li L, Sun Q. Identification of a novel biomarker-CCL5 using antibody microarray for colorectal cancer. Pathology - Research and Practice 2019;215:1033-7. [DOI: 10.1016/j.prp.2019.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
621 Knol AC, Nguyen JM, Pandolfino MC, Denis MG, Khammari A, Dréno B. PD-L1 expression by tumor cell lines: A predictive marker in melanoma. Exp Dermatol 2018;27:647-55. [PMID: 29505109 DOI: 10.1111/exd.13526] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
622 Semela D, Piguet AC, Kolev M, Schmitter K, Hlushchuk R, Djonov V, Stoupis C, Dufour JF. Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma. J Hepatol. 2007;46:840-848. [PMID: 17321636 DOI: 10.1016/j.jhep.2006.11.021] [Cited by in Crossref: 158] [Cited by in F6Publishing: 145] [Article Influence: 11.3] [Reference Citation Analysis]
623 Branza-nichita N, Petrareanu C, Lazar C, Sokolowska I, Darie CC. Using Proteomics to Unravel the Mysterious Steps of the HBV-Life-Cycle. In: Woods AG, Darie CC, editors. Advancements of Mass Spectrometry in Biomedical Research. Cham: Springer International Publishing; 2014. pp. 453-81. [DOI: 10.1007/978-3-319-06068-2_22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
624 Messersmith W, Laheru D, Hidalgo M. Recent advances in the pharmacological treatment of colorectal cancer. Expert Opinion on Investigational Drugs 2005;12:423-34. [DOI: 10.1517/13543784.12.3.423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
625 Chiba T, Hiraoka A, Mikami S, Shinozaki M, Osaki Y, Obu M, Ohki T, Mita N, Ledesma D, Yoshihara N, Beusterien K, Amos K, Bridges JF, Yokosuka O. Japanese patient preferences regarding intermediate to advanced hepatocellular carcinoma treatments. Patient Prefer Adherence 2019;13:637-47. [PMID: 31118587 DOI: 10.2147/PPA.S198363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
626 Speed N, Blair IA. Cyclooxygenase- and lipoxygenase-mediated DNA damage. Cancer Metastasis Rev 2011;30:437-47. [PMID: 22009064 DOI: 10.1007/s10555-011-9298-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
627 Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, Sumie S, Nagaoka S, Akiyoshi J, Inoue K, Torimura T, Kumashiro R, Ueno T, Sata M. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. J Clin Gastroenterol 2006;40:942-8. [PMID: 17063116 DOI: 10.1097/01.mcg.0000225675.14594.d6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
628 Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 2003;37:429-442. [PMID: 12540794 DOI: 10.1053/jhep.2003.50047] [Cited by in Crossref: 2017] [Cited by in F6Publishing: 1839] [Article Influence: 112.1] [Reference Citation Analysis]
629 Kim H, Um J, Kim Y. Association of a multidrug resistance 1 gene polymorphism and colorectal cancer in the Korean population. Orient Pharm Exp Med 2013;13:225-30. [DOI: 10.1007/s13596-013-0136-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
630 Zhang Z, Wang M, Wu D, Wang M, Tong N, Tian Y, Zhang Z. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies. Breast Cancer Res Treat 2010;120:509-17. [PMID: 19629678 DOI: 10.1007/s10549-009-0480-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
631 Lin CT, Hsu KF, Chen TW, Yu JC, Chan DC, Yu CY, Hsieh TY, Fan HL, Kuo SM, Chung KP, Hsieh CB. Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice? World J Surg. 2010;34:2155-2161. [PMID: 20407768 DOI: 10.1007/s00268-010-0598-x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
632 Goswami S, Sharma-Walia N. Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis. BMC Cancer 2015;15:935. [PMID: 26608463 DOI: 10.1186/s12885-015-1837-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
633 Umeda Y, Matsuda H, Sadamori H, Matsukawa H, Yagi T, Fujiwara T. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection. World J Surg. 2011;35:170-177. [PMID: 20922387 DOI: 10.1007/s00268-010-0794-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
634 Li N, Wu YR, Wu B, Lu MQ. Surgical and oncologic outcomes following laparoscopic versus open liver resection for hepatocellular carcinoma: A meta-analysis. Hepatol Res. 2012;42:51-59. [PMID: 21988222 DOI: 10.1111/j.1872-034x.2011.00890.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 25] [Article Influence: 5.7] [Reference Citation Analysis]
635 Yuan Z, Ye XD, Dong S, Xu LC, Xu XY, Liu SY, Xiao XS. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma. Eur J Radiol. 2010;75:e9-14. [PMID: 19540083 DOI: 10.1016/j.ejrad.2009.05.040] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
636 Hernández-hernández DM, Ornelas-bernal L, Guido-jiménez M, Apresa-garcia T, Alvarado-cabrero I, Salcedo-vargas M, Mohar-betancourt A, Garcia-carranca A. Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecologic Oncology 2003;90:310-7. [DOI: 10.1016/s0090-8258(03)00320-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
637 Schwartz JD, Llovet JM. Molecular Targeting in Hepatocellular Carcinoma. In: Kaufman HL, Wadler S, Antman K, editors. Molecular Targeting in Oncology. Totowa: Humana Press; 2008. pp. 165-210. [DOI: 10.1007/978-1-59745-337-0_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
638 Han T, Liu Z, Li H, Xie W, Zhang R, Zhu L, Guo F, Han Y, Sheng Y, Xie X. High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer. Onco Targets Ther 2015;8:1643-9. [PMID: 26185453 DOI: 10.2147/OTT.S81214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
639 Pan K, Zhao JJ, Wang H, Li JJ, Liang XT, Sun JC, Chen YB, Ma HQ, Liu Q, Xia JC. Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate. Int J Biol Sci 2010;6:639-48. [PMID: 20975822 DOI: 10.7150/ijbs.6.639] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
640 Ahmad W, Shabbiri K, Ijaz B, Asad S, Nazar N, Nazar S, Fouzia K, Kausar H, Gull S, Sarwar MT, Shahid I, Hassan S. Serine 204 phosphorylation and O-β-GlcNAC interplay of IGFBP-6 as therapeutic indicator to regulate IGF-II functions in viral mediated hepatocellular carcinoma. Virol J 2011;8:208. [PMID: 21548981 DOI: 10.1186/1743-422X-8-208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
641 Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. Exp Mol Pathol. 2011;90:66-73. [PMID: 20969862 DOI: 10.1016/j.yexmp.2010.10.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
642 Kang JY, Choi MS, Kim SJ, Kil JS, Lee JH, Koh KC, Paik SW, Yoo BC. Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma. Korean J Hepatol. 2010;16:383-388. [PMID: 21415582 DOI: 10.3350/kjhep.2010.16.4.383] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
643 Choi HJ, Kim SH, Seo SS, Kang S, Lee S, Kim JY, Kim YH, Lee JS, Chung HH, Lee JH, Park SY. MRI for pretreatment lymph node staging in uterine cervical cancer. AJR Am J Roentgenol 2006;187:W538-43. [PMID: 17056887 DOI: 10.2214/AJR.05.0263] [Cited by in Crossref: 72] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
644 Rao S, Cunningham D, de Gramont A, Scheithauer W, Smakal M, Humblet Y, Kourteva G, Iveson T, Andre T, Dostalova J. Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer. J Clin Oncol. 2004;22:3950-3957. [PMID: 15459217 DOI: 10.1200/JCO.2004.10.037] [Cited by in Crossref: 182] [Cited by in F6Publishing: 62] [Article Influence: 10.7] [Reference Citation Analysis]
645 Mao B, Hu F, Cheng J, Wang P, Xu M, Yuan F, Meng S, Wang Y, Yuan Z, Bi W. SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma. Oncogene. 2014;33:1468-1474. [PMID: 23542177 DOI: 10.1038/onc.2013.88] [Cited by in Crossref: 88] [Cited by in F6Publishing: 95] [Article Influence: 11.0] [Reference Citation Analysis]
646 Pereira JR, Fein L, del Giglio A, Blajman CR, Richardet E, Schwartsmann G, Orlando M, Hall BJ, West TM, van Kooten M. Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer. Lung Cancer 2007;58:80-7. [DOI: 10.1016/j.lungcan.2007.05.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
647 Valery PC, Moore SP, Meiklejohn J, Bray F. International variations in childhood cancer in indigenous populations: a systematic review. Lancet Oncol 2014;15:e90-e103. [PMID: 24480559 DOI: 10.1016/S1470-2045(13)70553-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
648 Gustavsson I, Juko-Pecirep I, Backlund I, Wilander E, Gyllensten U. Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia. J Clin Virol 2009;45:85-9. [PMID: 19451022 DOI: 10.1016/j.jcv.2009.04.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
649 Berenson JR. Therapeutic options in the management of myeloma bone disease. Semin Oncol 2010;37 Suppl 1:S20-9. [PMID: 20682368 DOI: 10.1053/j.seminoncol.2010.06.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
650 Li Y, Wang W, Wang W, Yang R, Wang T, Su T, Weng D, Tao T, Li W, Ma D. Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma. Gynecol Oncol. 2012;124:112-118. [PMID: 22018873 DOI: 10.1016/j.ygyno.2011.09.003] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
651 陈知水, 王海灏. 中国肝癌肝移植的现状与展望. 世界华人消化杂志 2006; 14(10): 939-941 [DOI: 10.11569/wcjd.v14.i10.939] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
652 Kim JS, Park YM, Kim NY, Yun HK, Lee KJ, Kim BH, Park SJ, Yeon JW, Jung G. Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results. Korean J Hepatol 2011;17:120-9. [PMID: 21757983 DOI: 10.3350/kjhep.2011.17.2.120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
653 Carter J. A contemporary review of uterine cancer management. Aust N Z J Obstet Gynaecol 2013;53:517-24. [DOI: 10.1111/ajo.12109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
654 Driessen JP, van Bemmel AJ, van Kempen PM, Janssen LM, Terhaard CH, Pameijer FA, Willems SM, Stegeman I, Grolman W, Philippens ME. Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas. Head Neck 2016;38 Suppl 1:E613-8. [PMID: 25783872 DOI: 10.1002/hed.24051] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
655 Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer. 2005;92:607-612. [PMID: 15685242 DOI: 10.1038/sj.bjc.6602333] [Cited by in Crossref: 118] [Cited by in F6Publishing: 123] [Article Influence: 7.4] [Reference Citation Analysis]
656 Rivera S, Keryer C, Busson P, Maingon P. Les carcinomes du nasopharynx : de la biologie à la clinique. Cancer/Radiothérapie 2005;9:55-68. [DOI: 10.1016/j.canrad.2004.12.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
657 Knol AC, Vallée A, Herbreteau G, Nguyen JM, Varey E, Gaultier A, Théoleyre S, Saint-Jean M, Peuvrel L, Brocard A, Quéreux G, Khammari A, Denis MG, Dréno B. Clinical significance of BRAF mutation status in circulating tumor DNA of metastatic melanoma patients at baseline. Exp Dermatol 2016;25:783-8. [PMID: 27194447 DOI: 10.1111/exd.13065] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
658 Price TR, Perkins SM, Sandrasegaran K, Henderson MA, Maluccio MA, Zook JE, Tector AJ, Vianna RM, Johnstone PA, Cardenes HR. Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma. Cancer. 2012;118:3191-3198. [PMID: 22025126 DOI: 10.1002/cncr.26404] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 8.6] [Reference Citation Analysis]
659 Arcidiacono D, Dedja A, Giacometti C, Fassan M, Nucci D, Francia S, Fabris F, Zaramella A, Gallagher EJ, Cassaro M, Rugge M, LeRoith D, Alberti A, Realdon S. Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model. Int J Mol Sci 2018;19:E1198. [PMID: 29662006 DOI: 10.3390/ijms19041198] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
660 Callegari E, Elamin BK, D’Abundo L, Falzoni S, Donvito G, Moshiri F, Milazzo M, Altavilla G, Giacomelli L, Fornari F. Anti-tumor activity of a miR-199-dependent oncolytic adenovirus. PLoS One. 2013;8:e73964. [PMID: 24069256 DOI: 10.1371/journal.pone.0073964] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
661 Goel H, Singhal S, Mathur R, Syeda S, Gupta RK, Kumar A, Shrivastava A, Jha AK. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population. Asian Pac J Cancer Prev 2020;21:1283-7. [PMID: 32458634 DOI: 10.31557/APJCP.2020.21.5.1283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
662 Zeng F, Tian L, Liu F, Cao J, Quan M, Sheng X. Induction of apoptosis by casticin in cervical cancer cells: reactive oxygen species-dependent sustained activation of Jun N-terminal kinase. Acta Biochim Biophys Sin (Shanghai) 2012;44:442-9. [PMID: 22427461 DOI: 10.1093/abbs/gms013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
663 Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, Ladurner R, Margreiter R, Vogel W. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl. 2007;13:272-279. [PMID: 17256758 DOI: 10.1002/lt.21033] [Cited by in Crossref: 183] [Cited by in F6Publishing: 156] [Article Influence: 13.1] [Reference Citation Analysis]
664 Moriña D, de Sanjosé S, Diaz M. Impact of model calibration on cost-effectiveness analysis of cervical cancer prevention. Sci Rep 2017;7:17208. [PMID: 29222509 DOI: 10.1038/s41598-017-17215-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
665 Ballardini P, Marri I, Margutti G, Aliberti C, Benea G, Manfredini R. Long-lasting Response with Metronomic Capecitabine in Advanced Hepatocellular Carcinoma. Tumori 2010;96:768-70. [DOI: 10.1177/030089161009600521] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
666 Eby PR, Lehman C. MRI-Guided Breast Interventions. Seminars in Ultrasound, CT and MRI 2006;27:339-50. [DOI: 10.1053/j.sult.2006.05.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
667 Delahaut G, Témam S, Ambroise J, Tao Y, Janot F, Van der Vorst S. Prognostic impact of tumor growth velocity in head and neck squamous cell carcinoma treated by radiotherapy: A pilot study. Head Neck 2019;41:3041-8. [PMID: 31087727 DOI: 10.1002/hed.25789] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
668 Flis E, Barber G, Nulty C, Keogh B, McGuirk P, Anand A, O'Sullivan J, Quante M, Creagh EM. Identification of TLR2 Signalling Mechanisms Which Contribute to Barrett's and Oesophageal Adenocarcinoma Disease Progression. Cancers (Basel) 2021;13:2065. [PMID: 33922955 DOI: 10.3390/cancers13092065] [Reference Citation Analysis]
669 Sabbir MG, Roy A, Mandal S, Dam A, Roychoudhury S, Panda CK. Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour. Int J Exp Pathol 2006;87:151-61. [PMID: 16623759 DOI: 10.1111/j.0959-9673.2006.00467.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
670 Gemmel C, Eickhoff A, Helmstädter L, Riemann JF. Pancreatic cancer screening: state of the art. Expert Rev Gastroenterol Hepatol. 2009;3:89-96. [PMID: 19210116 DOI: 10.1586/17474124.3.1.89] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
671 Ishikawa K, Kamohara Y, Tanaka F, Haraguchi N, Mimori K, Inoue H, Mori M. Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer. Br J Cancer. 2008;98:1824-1829. [PMID: 18506187 DOI: 10.1038/sj.bjc.6604379] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
672 Dubey AK, Gupta U, Jain S. Epidemiology of lung cancer and approaches for its prediction: a systematic review and analysis. Chin J Cancer 2016;35:71. [PMID: 27473753 DOI: 10.1186/s40880-016-0135-x] [Cited by in Crossref: 38]